{"content":"<li class=\"n-box-item date-title\" data-end=\"1529467199\" data-start=\"1529380800\" data-txt=\"Monday, December 23, 2019\">Tuesday, June 19, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3365075\" data-ts=\"1529450317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBP\" target=\"_blank\">IBP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365075-ibp-increases-size-maturity-of-credit-facilities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBP increases size, maturity of credit facilities</a></h4><ul>   <li>Installed Building Products (NYSE:<a href='https://seekingalpha.com/symbol/IBP' title='Installed Building Products, Inc.'>IBP</a>) has <a href=\"https://seekingalpha.com/pr/17196457-installed-building-products-announces-successful-increase-commitment-duration-term-loan-b\" target=\"_blank\">boosted the size</a> of its Term Loan B facility and its ABL revolving credit facility, and extended each maturity by about a year.</li>    <li>The Term Loan B (at $397.8M) now matures April 15, 2025, with pricing remaining at Libor plus 250 basis points (Libor floor of 1%). RBC, Jefferies and SunTrust were joint lead arrangers and joint book-runners.</li>    <li>The company's $150M revolver matures now on June 19, 2023. SunTrust was ABL agent and RBC Term Loan agent.</li>    <li>Shares are <font color='red'>1.5% lower</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365075\" data-linked=\"IBP increases size, maturity of credit facilities\" data-tweet=\"$IBP - IBP increases size, maturity of credit facilities https://seekingalpha.com/news/3365075-ibp-increases-size-maturity-of-credit-facilities?source=tweet\" data-url=\"https://seekingalpha.com/news/3365075-ibp-increases-size-maturity-of-credit-facilities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365073\" data-ts=\"1529449925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVG\" target=\"_blank\">CVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365073-convergysplus-4_3-on-report-of-potential-sale-to-synnex\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Convergys +4.3% on report of potential sale to Synnex</a></h4><ul>   <li>Call center operator Convergys (NYSE:<a href='https://seekingalpha.com/symbol/CVG' title='Convergys Corporation'>CVG</a>) is <font color='green'>up 4.3%</font> after hours on a Reuters report that Synnex (NYSE:<a href='https://seekingalpha.com/symbol/SNX' title='SYNNEX Corporation'>SNX</a>) is in <a href=\"https://www.reuters.com/article/us-convergys-m-a-synnex-corp-exclusive/exclusive-synnex-in-talks-to-acquire-call-center-operator-convergys-sources-idUSKBN1JF340\" target=\"_blank\">talks to buy it out</a>.</li>    <li>Synnex, a business process services company, has a market cap of $4.55B; Synnex is worth about $2.33B.</li>    <li>Convergys had previously spun off from Cincinnati Bell and became a separate public company in 1998. Its stock has <a href=\"https://seekingalpha.com/news/3355973-convergys-nearly-12-percent-sale-chatter\" target=\"_blank\">moved earlier this year</a> amid talk of a potential sale after its CEO's exit.</li>    <li>Synnex is <font color='green'>up 1.2%</font> after hours.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3365073\" data-linked=\"Convergys +4.3% on report of potential sale to Synnex\" data-tweet=\"$CVG $CVG $SNX - Convergys +4.3% on report of potential sale to Synnex https://seekingalpha.com/news/3365073-convergysplus-4_3-on-report-of-potential-sale-to-synnex?source=tweet\" data-url=\"https://seekingalpha.com/news/3365073-convergysplus-4_3-on-report-of-potential-sale-to-synnex\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365065\" data-ts=\"1529444128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGY\" target=\"_blank\">EGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365065-after-hours-gainers-losers-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (06/19/2018)</a></h4><ul>     <li><b>Top gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a>&nbsp;<font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a>&nbsp;<font color='green'>+1.4%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+1.3%</font>. <a href='https://seekingalpha.com/symbol/HAS' title='Hasbro, Inc.'>HAS</a>&nbsp;<font color='green'>+1.2%</font>. <a href='https://seekingalpha.com/symbol/YNDX' title='Yandex N.V.'>YNDX</a> <font color='green'>+0.95%</font>.</li>     <li><strong>Top Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a> <font color='red'>-6.7%</font>. <a href='https://seekingalpha.com/symbol/GDS' title='GDS Holdings'>GDS</a>&nbsp;<font color='red'>-3.2%</font>.&nbsp;&nbsp;<a href='https://seekingalpha.com/symbol/GOL' title='GOL Linhas AÃ©reas Inteligentes S.A.'>GOL</a>&nbsp;<font color='red'>-2.3%.&nbsp;</font><a href='https://seekingalpha.com/symbol/JOBS' title='51job, Inc.'>JOBS</a>&nbsp;<font color='red'>-1.9%</font>. <a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>&nbsp;<font color='red'>-1.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365065\" data-linked=\"After Hours Gainers / Losers (06/19/2018)\" data-tweet=\"$EGY $EGY $ARNC - After Hours Gainers / Losers (06/19/2018) https://seekingalpha.com/news/3365065-after-hours-gainers-losers-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3365065-after-hours-gainers-losers-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365045\" data-ts=\"1529441901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRTA\" target=\"_blank\">PRTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365045-prothena-up-1-after-publishing-positive-parkinsons-treatment-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prothena up 1% after publishing positive Parkinson&#39;s treatment data</a></h4><ul><li>Results from the Phase 1b study of&nbsp;PRX002/RG7935 showed acceptable safety and tolerability in patients with Parkinson's disease, thus meeting the trial's primary endpoint.</li><li>The results support advancing to the PASADENA Phase 2 study, which is currently ongoing.</li><li>The results were previously presented at a conference in April. They've now been published in JAMA Neurology.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17196369-prothena-announces-phase-1b-clinical-trial-results-prx002-rg7935-parkinsons-disease-published\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/PRTA' title='Prothena Corp plc'>PRTA</a>&nbsp;<font color='green'>+1.1%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3365045\" data-linked=\"Prothena up 1% after publishing positive Parkinson&#39;s treatment data\" data-tweet=\"$PRTA - Prothena up 1% after publishing positive Parkinson&#39;s treatment data https://seekingalpha.com/news/3365045-prothena-up-1-after-publishing-positive-parkinsons-treatment-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3365045-prothena-up-1-after-publishing-positive-parkinsons-treatment-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365036\" data-ts=\"1529440671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365036-mellanox-reaches-board-member-agreement-starboard\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mellanox reaches board member agreement with Starboard</a></h4><ul><li>           Mellanox (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a>) <a href=\"https://seekingalpha.com/pr/17196387-mellanox-announces-agreement-starboard\" target=\"_blank\">announces</a> reaching an agreement with activist investor Starboard. </li><li> Starboard-recommended directors Jon Olson and Greg Waters will join the Mellanox board along with Jack Lazar, an independent director mutually chosen by Mellanox and Starboard. Appointments are effective immediately. </li><li> Prior board members Dov Baharav, Shai Cohen, and Tom Riordan stepped down to make room for the new members. </li><li> Audit committee chair Thom Weatherford will stay on until March 2, 2019, and then step down. </li><li> Starboard has the right to appoint a direct representative to the board if Mellanox doesn&rsquo;t meet certain operating performance thresholds for FY18 or certain last twelve months periods during FY19. &nbsp; </li><li> Mellanox shares are&nbsp;<font color='red'>down 0.6%</font>&nbsp;aftermarket to $83.80.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3364489-reuters-mellanox-close-board-member-deal-starboard\" target=\"_blank\">Reuters: Mellanox close to board member deal with Starboard</a> (June 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365036\" data-linked=\"Mellanox reaches board member agreement with Starboard\" data-tweet=\"$MLNX - Mellanox reaches board member agreement with Starboard https://seekingalpha.com/news/3365036-mellanox-reaches-board-member-agreement-starboard?source=tweet\" data-url=\"https://seekingalpha.com/news/3365036-mellanox-reaches-board-member-agreement-starboard\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365035\" data-ts=\"1529440511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365035-sell-siders-defend-ptc-therapeutics-after-sarepta-stoked-31-plunge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-siders defend PTC Therapeutics after Sarepta-stoked 31% plunge</a></h4><ul><li>On cue, bullish sell-side analysts rush to defend PTC Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a>), down<font color='red'> 31%</font>&nbsp;on more than a 10x surge in volume today in apparent response to encouraging preliminary data on Sarepta Therapeutics' gene therapy candidate for Duchenne muscular dystrophy &#40;DMD&#41;.</li><li>William Blair's Raju Prasad (Outperform): Acknowledges that Sarepta's data are \"impressive,\" but cites the company's announced goal of a 15% CAGR for Translarna as one reason for longs to stay the course.</li><li>RBC's Brian Abrahams (Outperform/$45): Does not see \"major read-through\" from SRPT's gene therapy and does not expect its potential future success to \"necessarily dramatically impact\" PTC's long-term sales opportunity.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3365035\" data-linked=\"Sell-siders defend PTC Therapeutics after Sarepta-stoked 31% plunge\" data-tweet=\"$PTCT - Sell-siders defend PTC Therapeutics after Sarepta-stoked 31% plunge https://seekingalpha.com/news/3365035-sell-siders-defend-ptc-therapeutics-after-sarepta-stoked-31-plunge?source=tweet\" data-url=\"https://seekingalpha.com/news/3365035-sell-siders-defend-ptc-therapeutics-after-sarepta-stoked-31-plunge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365030\" data-ts=\"1529440136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365030-oracle-reports-q4-beats-8-cloud-services-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle reports Q4 beats with 8% Cloud Services growth</a></h4><ul><li>        Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>)&nbsp;<font color='green'>gains 0.8%</font>&nbsp;aftermarket on Q4 results that beat EPS and revenue estimates with a 3% Y/Y revenue growth. Guidance will come on the earnings call.</li><li>               Revenue breakdown: Cloud Services and License Support, $6.77B (+8% Y/Y); Cloud and On-Premise Software,&nbsp; $2.5B (-5%); Hardware, $1.12B (flat); Services, $883M (-1%).&nbsp;</li><li>               Key metrics: Total operating expenses, $6.87B (+1%); cash and equivalents, $21.62B; total liabilities (current and non-current), $91B.&nbsp;</li><li>               Earnings call is scheduled for 5 PM ET with webcast available <a href=\"http://investor.oracle.com/overview/highlights/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17196359-q4-fy18-gaap-eps-8-percent-0_82-non-gaap-eps-11-percent-0_99\" target=\"_blank\">Press release</a>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365009-oracle-beats-0_05-beats-revenue\" target=\"_blank\">Oracle beats by $0.05, beats on revenue</a> (June 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365016-oracle-declares-0_19-dividend\" target=\"_blank\">Oracle declares $0.19 dividend</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365030\" data-linked=\"Oracle reports Q4 beats with 8% Cloud Services growth\" data-tweet=\"$ORCL - Oracle reports Q4 beats with 8% Cloud Services growth https://seekingalpha.com/news/3365030-oracle-reports-q4-beats-8-cloud-services-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3365030-oracle-reports-q4-beats-8-cloud-services-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365029\" data-ts=\"1529440103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365029-fedex-slightly-higher-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx slightly higher after earnings</a></h4><ul><li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) pokes higher in AH trading after beating <a href=\"https://seekingalpha.com/pr/17196392-fedex-corp-reports-fourth-quarter-full-year-earnings\" target=\"_blank\">FQ4</a> estimates and updating guidance for the next fiscal year.</li><li>Operating income came in at $2.0B in FQ4 vs. $1.74B a year ago. Operating margin was up 40 bps to 11.5% of sales., which was on the top end of the company's guidance range. Operating margin in the ground segment was 17.3% of sales.</li><li>Looking ahead, the company sees FY19 EPS of $17.00 to $17.60 vs $17.47 consensus off revenue growth of 9%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365020-fedex-beats-0_23-beats-revenue\" target=\"_blank\">FedEx beats by $0.23, beats on revenue</a> (June 19)</li><li>FDX&nbsp;<font color='green'>+0.72%</font>&nbsp;AH to $260.24 after dropping 2.0% during the regular trading session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365029\" data-linked=\"FedEx slightly higher after earnings\" data-tweet=\"$FDX - FedEx slightly higher after earnings https://seekingalpha.com/news/3365029-fedex-slightly-higher-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3365029-fedex-slightly-higher-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365026\" data-ts=\"1529439736\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KALA\" target=\"_blank\">KALA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365026-kala-pharma-to-conduct-new-late-stage-study-for-dry-eye-disease-candidate-kpiminus-121-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kala Pharma to conduct new late-stage study for dry eye disease candidate KPI-121; shares up 1% after hours</a></h4><ul><li>Thinly traded micro cap Kala Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KALA' title='Kala Pharmaceuticals'>KALA</a>) perks up&nbsp;<font color='green'>1%</font>&nbsp;after hours following its announced <a href=\"https://seekingalpha.com/pr/17196347-kala-pharmaceuticals-announces-update-kpiminus-121-0_25-percent-development-plan\" target=\"_blank\">development update</a> for lead candidate KPI-121 0.25% in dry eye disease.</li><li>Despite uneven results from two earlier Phase 3 studies, it plans to submit its U.S. marketing application in H2. It also plans to launch another Phase 3 study, STRIDE 3, next quarter that it says should resolve the mixed results from STRIDE 1 &amp; 2. Topline data should be available in Q4 2019.</li><li>Concurrently, it is preparing for the potential FDA approval and market launch of KPI-121 1%, branded as INVELTYS, for the twice-daily treatment of postoperative ocular inflammation and pain. The agency's action date is August 24.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321384-kala-pharmas-lead-candidate-shows-mixed-results-two-late-state-dry-eye-disease-studies-shares\" target=\"_blank\">Kala Pharma's lead candidate shows mixed results in two late-state dry eye disease studies; shares down 16% premarket</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3365026\" data-linked=\"Kala Pharma to conduct new late-stage study for dry eye disease candidate KPI-121; shares up 1% after hours\" data-tweet=\"$KALA - Kala Pharma to conduct new late-stage study for dry eye disease candidate KPI-121; shares up 1% after hours https://seekingalpha.com/news/3365026-kala-pharma-to-conduct-new-late-stage-study-for-dry-eye-disease-candidate-kpiminus-121-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3365026-kala-pharma-to-conduct-new-late-stage-study-for-dry-eye-disease-candidate-kpiminus-121-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365023\" data-ts=\"1529439393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365023-s-and-p-downgrades-windstream-credit-on-exchange-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">S&amp;P downgrades Windstream credit on exchange offer</a></h4><ul>   <li>Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) finished the regular session <font color='green'>up 2%</font>, but S&amp;P has now downgraded the company's rating to CC from B-, with a negative outlook.</li>    <li>It's basing that on the stance that Windstream's <a href=\"https://seekingalpha.com/news/3364440-windstream-announces-exchange-offers-second-lien-notes\" target=\"_blank\">recent exchange offer</a> is a distressed transaction, with investors getting less than face value.</li>    <li>The negative outlook suggests that a completed exchange would have S&amp;P reducing the corporate credit rating to SD and ratings on affected issues to D.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365023\" data-linked=\"S&amp;P downgrades Windstream credit on exchange offer\" data-tweet=\"$WIN $WINMQ - S&amp;P downgrades Windstream credit on exchange offer https://seekingalpha.com/news/3365023-s-and-p-downgrades-windstream-credit-on-exchange-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3365023-s-and-p-downgrades-windstream-credit-on-exchange-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365013\" data-ts=\"1529438824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIN\" target=\"_blank\">KIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365013-kindred-bio-initiates-stock-offering-shares-off-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kindred Bio initiates stock offering; shares off 3% after hours</a></h4><ul><li>Kindred Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/KIN' title='Kindred Biosciences, Inc.'>KIN</a>) is down&nbsp;<font color='red'>3%</font>&nbsp;after hours in response to its announced <a href=\"https://seekingalpha.com/pr/17196351-kindred-biosciences-announces-proposed-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365013\" data-linked=\"Kindred Bio initiates stock offering; shares off 3% after hours\" data-tweet=\"$KIN - Kindred Bio initiates stock offering; shares off 3% after hours https://seekingalpha.com/news/3365013-kindred-bio-initiates-stock-offering-shares-off-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3365013-kindred-bio-initiates-stock-offering-shares-off-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365010\" data-ts=\"1529438700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APEN\" target=\"_blank\">APEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365010-apollo-endosurgery-launches-stock-offering-shares-down-34-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo Endosurgery launches stock offering; shares down 34% after hours</a></h4><ul><li>Apollo Endosurgery (NASDAQ:<a href='https://seekingalpha.com/symbol/APEN' title='Apollo Endosurgery'>APEN</a>) slumps&nbsp;<font color='red'>34%</font>&nbsp;after hours in response to its announced <a href=\"https://seekingalpha.com/pr/17196339-apollo-endosurgery-inc-announces-commencement-public-offering-common-stock\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3365010\" data-linked=\"Apollo Endosurgery launches stock offering; shares down 34% after hours\" data-tweet=\"$APEN - Apollo Endosurgery launches stock offering; shares down 34% after hours https://seekingalpha.com/news/3365010-apollo-endosurgery-launches-stock-offering-shares-down-34-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3365010-apollo-endosurgery-launches-stock-offering-shares-down-34-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365009\" data-ts=\"1529438627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365009-oracle-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle beats by $0.05, beats on revenue</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>): Q4 EPS of $0.99 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $11.25B (+2.8% Y/Y) <font color='green'>beats by $60M</font>.</li><li>Shares <font color='green'>+1.5%</font>.</li><li><a href='https://seekingalpha.com/pr/17196359-q4-fy18-gaap-eps-8-percent-0_82-non-gaap-eps-11-percent-0_99'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3365009\" data-linked=\"Oracle beats by $0.05, beats on revenue\" data-tweet=\"$ORCL - Oracle beats by $0.05, beats on revenue https://seekingalpha.com/news/3365009-oracle-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3365009-oracle-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365004\" data-ts=\"1529437552\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365004-dow-underperforms-trade-war-whacks-cat-boeing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dow underperforms as trade war whacks CAT, Boeing</a></h4><ul><li>The S&amp;P 500 and Nasdaq are&nbsp;<font color='red'>down just a modest 0.5%</font>, but the DJIA (NYSEARCA:<a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>) is&nbsp;<font color='red'>lower by 1.3%</font>&nbsp;after amped up trade war chatter between China and the U.S. Worst performers on a percentage basis are Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='red'>-4%</font>) and Caterpillar (<a href='https://seekingalpha.com/symbol/CAT' title='Caterpillar Inc.'>CAT</a> <font color='red'>-3.9%</font>), followed by DowDuPont (<a href='https://seekingalpha.com/symbol/DWDP' title='DowDuPont Inc.'>DWDP</a> <font color='red'>-2.3%</font>) and 3M (<a href='https://seekingalpha.com/symbol/MMM' title='3M Company'>MMM</a> <font color='red'>-2.6%</font>).</li><li>In the green are more defensive plays like Verizon, J&amp;J, and Procter &amp; Gamble.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364766-trade-war-china-leads-world-markets-lower\" target=\"_blank\">Trade war: China leads world markets lower</a> (June 19)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/DIA' title='SPDR Dow Jones Industrial Average ETF'>DIA</a>, <a href='https://seekingalpha.com/symbol/UDOW' title='ProShares UltraPro Dow 30 ETF'>UDOW</a>, <a href='https://seekingalpha.com/symbol/DOG' title='ProShares Short Dow 30 ETF'>DOG</a>, <a href='https://seekingalpha.com/symbol/DXD' title='ProShares UltraShort Dow30 ETF'>DXD</a>, <a href='https://seekingalpha.com/symbol/SDOW' title='ProShares UltraPro Short Dow 30 ETF'>SDOW</a>, <a href='https://seekingalpha.com/symbol/DDM' title='ProShares Ultra Dow 30 ETF'>DDM</a>, <a href='https://seekingalpha.com/symbol/EDOW' title='First Trust Dow 30 Equal Weight ETF'>EDOW</a>, <a href='https://seekingalpha.com/symbol/UDPIX' title='ProFunds Ultra Dow 30 ProFund Inv'>UDPIX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3365004\" data-linked=\"Dow underperforms as trade war whacks CAT, Boeing\" data-tweet=\"$BA $DIA $BA - Dow underperforms as trade war whacks CAT, Boeing https://seekingalpha.com/news/3365004-dow-underperforms-trade-war-whacks-cat-boeing?source=tweet\" data-url=\"https://seekingalpha.com/news/3365004-dow-underperforms-trade-war-whacks-cat-boeing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3365002\" data-ts=\"1529436727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3365002-nokia-orange-conduct-successful-ran-trial-for-5g\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia, Orange conduct successful RAN trial for 5G</a></h4><ul>   <li>Another micro-move in 5G development sees Nokia (<a href=\"http://seekingalpha.com/symbol/NOK\" target=\"_blank\">NOK</a> <font color='red'>-1.7%</font>) conducting its first <a href=\"https://seekingalpha.com/pr/17195043-nokia-collaboration-orange-applies-cloud-benefits-radio-access-large-scale-trial-preparing\" target=\"_blank\">cloud radio access network trial</a> using Orange's (<a href=\"http://seekingalpha.com/symbol/ORAN\" target=\"_blank\">ORAN</a> <font color='red'>-0.1%</font>) cloud infrastructure platform.</li>    <li>The test, in Poland, is preparation for Orange's future distributed cloud architecture for 5G.</li>    <li>\"The quality and performance observed during the trial give confidence on the RAN virtualization and is a critical step for us towards 5G,\" says Orange Poland's Piotr Jaworski.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3365002\" data-linked=\"Nokia, Orange conduct successful RAN trial for 5G\" data-tweet=\"$NOK $NOK $ORAN - Nokia, Orange conduct successful RAN trial for 5G https://seekingalpha.com/news/3365002-nokia-orange-conduct-successful-ran-trial-for-5g?source=tweet\" data-url=\"https://seekingalpha.com/news/3365002-nokia-orange-conduct-successful-ran-trial-for-5g\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364998\" data-ts=\"1529435090\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XEC\" target=\"_blank\">XEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364998-cimarex-energy-continues-nearly-10-two-day-surge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cimarex Energy continues nearly 10% two-day surge</a></h4><ul>     <li>Cimarex Energy (<a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a> <font color='green'>+3.5%</font>) surges for a second straight day after Cowen analyst Charles Robertson <a href=\"https://thefly.com/thestreet/realmoney/index.php/XECid2747209/XEC-Cimarex-Energy-second-half-ramp-fears-overdone-says-Cowen\" target=\"_blank\">reiterates an Outperform rating</a> on the shares and raises his stock price target to $130 from $115.</li><li>Robertson thinks investor fears about the H2 ramp at XEC are overdone since the company has the firm capacity to achieve its 2018-19 production growth while also maintaining a strong balance sheet.</li><li>XEC jumped 5.7% in <a href=\"https://seekingalpha.com/news/3364757-energy-stocks-dominate-todays-s-and-p-movers-cimarex-plus-5_7-percent\" target=\"_blank\">yesterday</a>'s trade, the biggest gainer among a wave of rising energy shares; shares have soared ~9.5% in two days.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364998\" data-linked=\"Cimarex Energy continues nearly 10% two-day surge\" data-tweet=\"$XEC - Cimarex Energy continues nearly 10% two-day surge https://seekingalpha.com/news/3364998-cimarex-energy-continues-nearly-10-two-day-surge?source=tweet\" data-url=\"https://seekingalpha.com/news/3364998-cimarex-energy-continues-nearly-10-two-day-surge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364994\" data-ts=\"1529434605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LFIN\" target=\"_blank\">LFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364994-technology-top-5-gainers-losers-of-2_55-pm-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (06/19/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/OCC' title='Optical Cable Corporation'>OCC</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/COTV' title='Cotiviti Holdings'>COTV</a> <font color='green'>+10%</font>. LFGR <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/AMRH' title='Ameri Holdings, Inc.'>AMRH</a> <font color='green'>+6%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/SYX' title='Systemax Inc.'>SYX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black'>CBLK</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SOGO' title='Sogou'>SOGO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364994\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (06/19/2018)\" data-tweet=\"$LFIN $LFIN $OCC - Technology - Top 5 Gainers / Losers as of 2.55 PM (06/19/2018) https://seekingalpha.com/news/3364994-technology-top-5-gainers-losers-of-2_55-pm-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364994-technology-top-5-gainers-losers-of-2_55-pm-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364992\" data-ts=\"1529434265\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNTR-OLD\" target=\"_blank\">TNTR-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364992-tintriminus-22_2-on-continued-volatility-high-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tintri -22.2% on continued volatility, high volume</a></h4><ul><li>Tintri (NASDAQ:<a href='https://seekingalpha.com/symbol/TNTR-OLD' title='Tintri, Inc.'>TNTR-OLD</a>) remains volatile after announcing last week that it might lack the liquidity to continue beyond June 30.</li><li>Current volume is 3.3M compared to the 1.52M average.</li><li>Tintri shares are&nbsp;<font color='red'>down 52.7%</font>&nbsp;in the past week,&nbsp;<font color='red'>77%</font>&nbsp;in the past month, and&nbsp;<font color='red'>95.1%</font>&nbsp;YTD.</li><li>Tintri shares are&nbsp;<font color='red'>down 22.2%</font>&nbsp;to $0.20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364249-tintri-lacks-liquidity-continue-beyond-june-30-tntr-minus-39_5-percent\" target=\"_blank\">Tintri lacks liquidity to continue beyond June 30; TNTR -39.5%</a> (June 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364992\" data-linked=\"Tintri -22.2% on continued volatility, high volume\" data-tweet=\"$TNTR-OLD - Tintri -22.2% on continued volatility, high volume https://seekingalpha.com/news/3364992-tintriminus-22_2-on-continued-volatility-high-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3364992-tintriminus-22_2-on-continued-volatility-high-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364990\" data-ts=\"1529433615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364990-amd-alibaba-dip-on-high-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD, Alibaba dip on high volume</a></h4><ul><li>        Information Technology stocks moving on high volume include AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) and Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>).</li><li>               AMD shares are&nbsp;<font color='red'>down 2.6%</font>&nbsp;with volume at about 74.35M compared to the 58.35M average.&nbsp;</li><li>               Alibaba shares are&nbsp;<font color='red'>down 2.2%</font>&nbsp;with volume at around 19.34M compared to the 17.44M average. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364990\" data-linked=\"AMD, Alibaba dip on high volume\" data-tweet=\"$AMD $AMD $BABA - AMD, Alibaba dip on high volume https://seekingalpha.com/news/3364990-amd-alibaba-dip-on-high-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/3364990-amd-alibaba-dip-on-high-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364988\" data-ts=\"1529433459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDLS\" target=\"_blank\">NDLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364988-noodles-breaks-to-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noodles breaks to new high</a></h4><ul> <li>Noodles (<a href='https://seekingalpha.com/symbol/NDLS' title='Noodles & Company'>NDLS</a> <font color='green'>+7.5%</font>) trades higher after management presented today at the Jefferies 2018 Consumer Conference.</li> <li>Shares of the restaurant operator carved out a new 52-week high of $11.55 earlier.</li><li>Short interest on Noodles represents more than 10% of outstanding shares.</li> <li><a href=\"http://wsw.com/webcast/jeff112/register.aspx?conf=jeff112&amp;page=ndls&amp;url=http://wsw.com/webcast/jeff112/ndls/index.aspx\" target=\"_blank\">Noodles investor presentation webcast</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364988\" data-linked=\"Noodles breaks to new high\" data-tweet=\"$NDLS - Noodles breaks to new high https://seekingalpha.com/news/3364988-noodles-breaks-to-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3364988-noodles-breaks-to-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364972\" data-ts=\"1529433428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RENN\" target=\"_blank\">RENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364972-on-renren-s-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Renren &#39;s Q1 results</a></h4><ul><li>Renren (<a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>) reported Q1 revenue growth of 570% Y/Y to $140.6M due to the launch of the used car retail business in the 2Q17.</li><li>Segment revenues: Internet value added services $14.7M (+26.5% Y/Y), Financing income $2.2M (-76.4% Y/Y) and Used cars sales $123.6M.</li><li>Q1 Overall margins: Gross&nbsp;<font color='red'>declined by 2,229 bps</font>&nbsp;to 8.5% and operating&nbsp;<font color='green'>recovered by 6,585 bps</font>&nbsp;to -18.2%</li><li>Q1 Expenses: Selling &amp; marketing $11.9M (+92.9% Y/Y), R&amp;D $7.3M (+26.9% Y/Y) and G&amp;A $18.2M (+50.6% Y/Y).</li><li><a href=\"https://seekingalpha.com/pr/17144875-renren-announces-cash-dividend-private-placement-adoption-share-repurchase-plan\" target=\"_blank\">The Transaction</a> announced on April 30, 2018 was intended to address concerns that Renren may be deemed to be an investment company within the meaning of the Investment Company Act and is expected to close on June 21, 2018. The Transaction will have a significant impact on the Company's financial statements.</li><li>2Q18 Outlook: Revenue $140-145M (+527%-549% Y/Y).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364842-renren-reports-q1-results\" target=\"_blank\">Renren reports Q1 results</a> (June 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3350277-renren-announces-dividend-private-placement-shares-minus-4_7-percent\" target=\"_blank\">Renren announces dividend, private placement; shares -4.7%</a> (April 30)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364972\" data-linked=\"More on Renren &#39;s Q1 results\" data-tweet=\"$RENN - More on Renren &#39;s Q1 results https://seekingalpha.com/news/3364972-on-renren-s-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364972-on-renren-s-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364986\" data-ts=\"1529432734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364986-nyts-social-media-relations-googles-good-facebooks-failing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NYT&#39;s social media relations: Google&#39;s good, Facebook&#39;s failing</a></h4><ul>   <li>Speaking in Cannes, New York Times (<a href=\"http://seekingalpha.com/symbol/NYT\" target=\"_blank\">NYT</a> <font color='red'>-0.2%</font>) CEO Mark Thompson has given a review of his company's <a href=\"https://digiday.com/media/new-york-times-ceo-facebook-difficult\" target=\"_blank\">news relationship with social media platforms</a> -- and from his perspective, Facebook's (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='red'>-0.6%</font>) declining while Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='red'>-0.9%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='red'>-1.1%</font>) is resurgent.</li>    <li>&ldquo;Although we have a long list of things we&rsquo;d like to talk to Google about, it&rsquo;s actually a genuinely quite creative, positive environment,&rdquo; Thompson says, noting the company is listening and taking action on things like a first-click-free policy on articles, allowing NYT to set more parameters for how people access its news.</li>    <li>Meanwhile: &ldquo;Facebook we have found to be very difficult,&rdquo; he says, noting a recent issue-ad policy that conflates news articles with political and advocacy ads. He notes a recent cake recipe that \"may contain nuts\" but no political content that went straight into Facebook's archive for political ads.</li>    <li>As for Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='red'>-2.4%</font>), it's \"becoming an exciting and interesting platform again,&rdquo; Thompson says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364986\" data-linked=\"NYT&#39;s social media relations: Google&#39;s good, Facebook&#39;s failing\" data-tweet=\"$GOOG $GOOG $GOOGL - NYT&#39;s social media relations: Google&#39;s good, Facebook&#39;s failing https://seekingalpha.com/news/3364986-nyts-social-media-relations-googles-good-facebooks-failing?source=tweet\" data-url=\"https://seekingalpha.com/news/3364986-nyts-social-media-relations-googles-good-facebooks-failing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364985\" data-ts=\"1529432526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364985-white-house-denies-iphone-tariff-exemption-cook-calls-border-separations-inhumane\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">White House denies iPhone tariff exemption; Cook calls border separations &quot;inhumane&quot;</a></h4><ul><li>        White House trade advisor Peter Navarro <a href=\"https://www.cnbc.com/2018/06/19/white-houses-navarro-on-china-trade-talks-no-knowledge-of-apple-iphone-exemption.html\" target=\"_blank\">says</a> he does not know of an Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) iPhone exemption in the U.S. trade talks with China. &nbsp;</li><li>        Navarro&rsquo;s comment follows a The New York Times piece that said the Trump administration told CEO Tim Cook there wouldn&rsquo;t be tariffs on iPhones assembled in China. &nbsp;</li><li>        Meanwhile, Tim Cook <a href=\"https://www.irishtimes.com/news/world/us/apple-chief-tim-cook-condemns-inhumane-us-detention-of-children-1.3536224\" target=\"_blank\">calls</a> the administration&rsquo;s separation of children from their parents at the border &ldquo;inhumane&rdquo; and &ldquo;heartbreaking.&rdquo;</li><li>               Cook, to The Irish Times: &ldquo;It&rsquo;s heartbreaking to see the images and hear the sounds of the kids. Kids are the most vulnerable people in any society. I think that what&rsquo;s happening is inhumane, it needs to stop.&rdquo;&nbsp;&nbsp;</li><li>               Apple shares are&nbsp;<font color='red'>down 1.6%</font>&nbsp;to $185.66.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364762-iphones-intel-chips-exempt-tariffs\" target=\"_blank\">iPhones, Intel chips exempt from tariffs?</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364985\" data-linked=\"White House denies iPhone tariff exemption; Cook calls border separations &quot;inhumane&quot;\" data-tweet=\"$AAPL - White House denies iPhone tariff exemption; Cook calls border separations &quot;inhumane&quot; https://seekingalpha.com/news/3364985-white-house-denies-iphone-tariff-exemption-cook-calls-border-separations-inhumane?source=tweet\" data-url=\"https://seekingalpha.com/news/3364985-white-house-denies-iphone-tariff-exemption-cook-calls-border-separations-inhumane\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>287&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364979\" data-ts=\"1529431255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364979-energy-materials-top-5-gainers-losers-of-2-00-pm-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+78%</font>. <a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/MPO' title='Midstates Petroleum'>MPO</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/PLM' title='PolyMet Mining Corp'>PLM</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GSV' title='Gold Standard Ventures'>GSV</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SSRM' title='SSR Mining Inc'>SSRM</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CENX' title='Century Aluminum Company'>CENX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/ZEUS' title='Olympic Steel, Inc.'>ZEUS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364979\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/19/2018)\" data-tweet=\"$GEVO $GEVO $MCF - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (06/19/2018) https://seekingalpha.com/news/3364979-energy-materials-top-5-gainers-losers-of-2-00-pm-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364979-energy-materials-top-5-gainers-losers-of-2-00-pm-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364974\" data-ts=\"1529430950\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364974-netflix-scratches-400-off-bucket-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix scratches $400 off its bucket list</a></h4><ul> <li>Shares of Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+2.7%</font>) crossed over $400 for the first time ever within the last thirty minutes as this morning's bull rush of analyst notes buoyed sentiment again.</li><li>The new high mark for Netflix is $401.28.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3364908-wall-street-stop-loving-netflix\" target=\"_blank\">Wall Street can't stop loving Netflix</a> (June 19)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3364974\" data-linked=\"Netflix scratches $400 off its bucket list\" data-tweet=\"$NFLX - Netflix scratches $400 off its bucket list https://seekingalpha.com/news/3364974-netflix-scratches-400-off-bucket-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3364974-netflix-scratches-400-off-bucket-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364973\" data-ts=\"1529430520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364973-sareptaplus-37_5-sell-side-chimes-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta +37.5% as sell-side chimes in</a></h4><ul><li>\"If you want to own something really transformative, buy this stock,\" says Baird bull Brian Skorney. \"&ldquo;If durable, this will transform the lives of DMD patients in the future.\"</li><li>Also a bull, RBC's Brain Abrahams sounds a modest note of caution. \"While dramatic and far exceeding expectations, we acknowledge that there are still some outstanding questions, as the results are early and interim.\"</li><li>Chardan's&nbsp;Gbola Amusa says the news is a positive for Solid Biosciences (<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+55.7%</font>), seeing &ldquo;superior elements of the Solid microdystrophin construct.\"</li><li>\"Transitioning to the next emerging large-cap,\" says JPMorgan, jacking its price target to $205.</li><li>HC Wainwright goes further, raising to $267.</li><li>Source: Bloomberg</li><li><a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>&nbsp;<font color='green'>+37.5%&nbsp;</font>to $144.69.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364906-sarepta-set-pop-encouraging-data-dmd-gene-therapy\" target=\"_blank\">Sarepta set to pop on encouraging data on DMD gene therapy</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364973\" data-linked=\"Sarepta +37.5% as sell-side chimes in\" data-tweet=\"$SLDB $SLDB $SRPT - Sarepta +37.5% as sell-side chimes in https://seekingalpha.com/news/3364973-sareptaplus-37_5-sell-side-chimes-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3364973-sareptaplus-37_5-sell-side-chimes-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364971\" data-ts=\"1529430321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364971-disappointing-read-on-u-s-appliances-shipments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disappointing read on U.S. appliances shipments</a></h4><ul> <li>Whirlpool (<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a> <font color='red'>-2.5%</font>) is down sharply after the Association of Home Appliance Manufacturers <a href=\"https://www.aham.org/\" target=\"_blank\">reports</a> a 4.7% drop in major home appliances shipments during May and a 10.5% decline in the key AHAM 6 category.</li> <li>Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color='red'>-1.1%</font>), Home Depot (<a href='https://seekingalpha.com/symbol/HD' title='Home Depot, Inc.'>HD</a> <font color='red'>-1.1%</font>) and Electrolux (<a href='https://seekingalpha.com/symbol/ELUXF' title='AB Electrolux'>OTCPK:ELUXF</a>, <a href='https://seekingalpha.com/symbol/ELUXY' title='AB Electrolux ADR B'>OTCPK:ELUXY</a>) also frequently see share prices movements after the monthly AHAM data is posted.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3364971\" data-linked=\"Disappointing read on U.S. appliances shipments\" data-tweet=\"$WHR $WHR $BBY - Disappointing read on U.S. appliances shipments https://seekingalpha.com/news/3364971-disappointing-read-on-u-s-appliances-shipments?source=tweet\" data-url=\"https://seekingalpha.com/news/3364971-disappointing-read-on-u-s-appliances-shipments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364967\" data-ts=\"1529429291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364967-t-also-pledges-to-cut-off-sales-of-user-location-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T also pledges to cut off sales of user location data</a></h4><ul>   <li>AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+0.5%</font>) is also joining in with a pledge to <a href=\"https://finance.yahoo.com/news/latest-t-vows-cut-off-171709292.html\" target=\"_blank\">cut off selling its users' phone location data</a> to outside brokers.</li>    <li>Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='green'>+2.1%</font>) told Sen. Ron Wyden that it's <a href=\"https://seekingalpha.com/news/3364945-verizon-ending-location-sharing-leaks\" target=\"_blank\">ending such sharing</a> after the discovery that at least one partner was sharing customer locations without permission. Wyden has asked all four major U.S. wireless providers for details on their privacy practices.</li>    <li>AT&amp;T says it will stop sharing the data as soon as practical, with the hurdle being ensuring that services like emergency roadside service aren't affected.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364967\" data-linked=\"AT&amp;T also pledges to cut off sales of user location data\" data-tweet=\"$T $T $VZ - AT&amp;T also pledges to cut off sales of user location data https://seekingalpha.com/news/3364967-t-also-pledges-to-cut-off-sales-of-user-location-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3364967-t-also-pledges-to-cut-off-sales-of-user-location-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364964\" data-ts=\"1529429145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MEDFF\" target=\"_blank\">MEDFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364964-medreleaf-corp-up-4_2-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medreleaf Corp up 4.2% post Q4 results</a></h4><ul><li>Medreleaf Corp (<a href='https://seekingalpha.com/symbol/MEDFF' title='Medreleaf Corp.'>OTCPK:MEDFF</a> <font color='green'>+4.2%</font>)&nbsp;<a href=\"https://investors.medreleaf.com/English/press-releases/press-release-details/2018/MedReleaf-Reports-Fourth-Quarter-and-Year-End-Fiscal-2018-Results/default.aspx\" target=\"_blank\">reports Q4</a> revenue growth of 15.9% Y/Y to C$12M, the growth was the result of increased production capacity, patient demand, yield improvements, and the continued growth of cannabis oil extracts for sale.</li><li>1,425 adj. kilograms (+19% Y/Y) of cannabis products were sold at an average selling price of&nbsp;C$8.43&nbsp;per adj. gram (-2.7% Y/Y).</li><li>Adj. EBITDA loss of&nbsp;C$4.7M, a decrease was due to increased overhead costs and investments in recreational brands, international business initiatives, and increased R&amp;D efforts.</li><li>Adj. cash cost per gram sold of&nbsp;C$1.4 (-6% Y/Y), a decrease was due to increased production and yield improvements that resulted in improved efficiencies in labour utilization and allocation of fixed costs.</li><li>Adj. product contribution margin was C$8.5M (+14.9% Y/Y) &amp; Adj. product contribution margin per gram sold of&nbsp;C$5.94 (-3.9% Y/Y).</li><li>The company introduced Equiposa, Orellium and Trutiva &ndash; three proprietary varieties of premium medical cannabis developed by&nbsp;MedReleaf's internal R&amp;D program.</li><li>Also, entered into an exclusive licensing agreement with&nbsp;Woodstook Cannabis Company&nbsp;for the use of the iconic Woodstock brand in the Canadian cannabis market.</li><li>Signed an agreement to become the largest supplier to&nbsp;Cannamedical Pharma GmbH, a leading medical cannabis distributor in Germany&nbsp;with a network of over 1,800 pharmacies.</li><li>Cash and equivalents of&nbsp;C$215.9M&nbsp;and working capital of&nbsp;C$255.7M</li><li>Capex was&nbsp;C$40.9M&nbsp;primarily put towards production rooms, building improvements, furniture and other equipment related to the construction and development of the Bradford Facility.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364905-medreleaf-corp-reports-q4-results\" target=\"_blank\">Medreleaf Corp. reports Q4 results</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364964\" data-linked=\"Medreleaf Corp up 4.2% post Q4 results\" data-tweet=\"$MEDFF - Medreleaf Corp up 4.2% post Q4 results https://seekingalpha.com/news/3364964-medreleaf-corp-up-4_2-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364964-medreleaf-corp-up-4_2-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364963\" data-ts=\"1529428442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364963-deutsche-bank-sees-multiple-upsides-for-verizon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank sees multiple upsides for Verizon</a></h4><ul>   <li>Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='green'>+2.2%</font>) is seeing better fundamentals in wireless, Deutsche Bank says, with stabilizing pricing and the prospect that hot competition could ease a bit with disruptors Sprint and T-Mobile <a href=\"https://seekingalpha.com/news/3364950-t-mobile-sprint-formally-file-fcc-merger\" target=\"_blank\">pushing forward with a potential merger</a>.</li>    <li>Meanwhile, digital advertising is promising as well with headroom above, the bank says, with Oath holding only about 4% of a $100B market. And the company has upside from 5G ahead as well. (h/t Bloomberg)</li>    <li>DB's upgraded shares to Buy with a $56 price target, implying 15%-plus upside from current pricing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364963\" data-linked=\"Deutsche Bank sees multiple upsides for Verizon\" data-tweet=\"$VZ - Deutsche Bank sees multiple upsides for Verizon https://seekingalpha.com/news/3364963-deutsche-bank-sees-multiple-upsides-for-verizon?source=tweet\" data-url=\"https://seekingalpha.com/news/3364963-deutsche-bank-sees-multiple-upsides-for-verizon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364959\" data-ts=\"1529427665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FBNK\" target=\"_blank\">FBNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364959-financials-top-5-gainers-losers-of-1-00-pm-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (06/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FBNK' title='First Connecticut Bancorp, Inc.'>FBNK</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/VCTR' title='Victory Capital Holdings, Inc.'>VCTR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BBD' title='Banco Bradesco, S.A.'>BBD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/GRBK' title='Green Brick Partners, Inc'>GRBK</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364959\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (06/19/2018)\" data-tweet=\"$FBNK $PBCT $VCTR - Financials - Top 5 Gainers / Losers as of 1:00 PM (06/19/2018) https://seekingalpha.com/news/3364959-financials-top-5-gainers-losers-of-1-00-pm-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364959-financials-top-5-gainers-losers-of-1-00-pm-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364956\" data-ts=\"1529427009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HP\" target=\"_blank\">HP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364956-helmerich-payne-upped-to-buy-jefferies-seeing-permian-falloff-shallow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Helmerich &amp; Payne upped to Buy at Jefferies, seeing Permian falloff shallow</a></h4><ul>     <li>Helmerich &amp; Payne (<a href='https://seekingalpha.com/symbol/HP' title='Helmerich & Payne Inc.'>HP</a> <font color='green'>+1.4%</font>) is higher after Jefferies <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/06/11901142/any-permian-fall-off-for-helmerich-payne-is-shallow-jef\" target=\"_blank\">upgrades shares to Buy</a> from Hold with an $80 price target, raised from $72, saying the 13% pullback over the past month is unwarranted.</li>     <li>Shares of land drillers are down 21% since mid-May as investors fret over potential Permian activity decline and the recent oil weakness, but Jefferies analyst Brad Handler believes any Permian drop-off will be shallow and limited to H2 of the year.</li>     <li>\"HP retains best-in-class exposure to a super-spec rig market that should tighten further and allow for strong [free cash flow] inflection through the next 24 months,\" Handler writes, adding that U.S. land drilling fundamentals remain strong.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364956\" data-linked=\"Helmerich &amp; Payne upped to Buy at Jefferies, seeing Permian falloff shallow\" data-tweet=\"$HP - Helmerich &amp; Payne upped to Buy at Jefferies, seeing Permian falloff shallow https://seekingalpha.com/news/3364956-helmerich-payne-upped-to-buy-jefferies-seeing-permian-falloff-shallow?source=tweet\" data-url=\"https://seekingalpha.com/news/3364956-helmerich-payne-upped-to-buy-jefferies-seeing-permian-falloff-shallow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364955\" data-ts=\"1529426898\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIMO\" target=\"_blank\">SIMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364955-silicon-motionplus-3_3-needham-sees-18-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Silicon Motion +3.3% as Needham sees 18% upside</a></h4><ul><li>        Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Silicon+Motion+Technology+%28SIMO%29+PT+Raised+to+%2460+at+Needham+%26+Company+Citing+NAND+Supply+and+Client+SSD+Attach+Rates/14319522.html\" target=\"_blank\">maintains</a> a Buy rating on Silicon Motion (NASDAQ:<a href='https://seekingalpha.com/symbol/SIMO' title='Silicon Motion Technology Corporation'>SIMO</a>) and raises its price target from $57 to $60.</li><li>               New target represents a nearly 18% upside to yesterday&rsquo;s close.&nbsp;</li><li>               Silicon Motion shares are&nbsp;<font color='green'>up 3.3%</font>&nbsp;to $52.70.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364955\" data-linked=\"Silicon Motion +3.3% as Needham sees 18% upside\" data-tweet=\"$SIMO - Silicon Motion +3.3% as Needham sees 18% upside https://seekingalpha.com/news/3364955-silicon-motionplus-3_3-needham-sees-18-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3364955-silicon-motionplus-3_3-needham-sees-18-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364952\" data-ts=\"1529426758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSO\" target=\"_blank\">PSO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364952-pearsonminus-2_2-credit-suisse-cuts-to-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pearson -2.2% as Credit Suisse cuts to Underperform</a></h4><ul>   <li>Pearson (NYSE:<a href='https://seekingalpha.com/symbol/PSO' title='Pearson plc'>PSO</a>) is <font color='red'>2.2% lower</font> after a cut to Underperform at Credit Suisse.</li>    <li>Shares just hit their 52-week high of $12.51 May 11, and the stock is about 9.6% below that point currently.</li>    <li>That's one of a small string of downgrades the stock has seen over the past several weeks; BNP Paribas cut its rating to Neutral from Outperform, and last week Barclays downgraded to Underweight from Equal Weight.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364952\" data-linked=\"Pearson -2.2% as Credit Suisse cuts to Underperform\" data-tweet=\"$PSO - Pearson -2.2% as Credit Suisse cuts to Underperform https://seekingalpha.com/news/3364952-pearsonminus-2_2-credit-suisse-cuts-to-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3364952-pearsonminus-2_2-credit-suisse-cuts-to-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364953\" data-ts=\"1529426712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASTC\" target=\"_blank\">ASTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364953-midday-gainers-losers-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (06/19/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a> <font color='green'>+205%</font>. <a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+82%</font>. <a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+59%</font>. <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/FMI' title='Foundation Medicine, Inc.'>FMI</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/SRRK' title='Scholar Rock Holding'>SRRK</a> <font color='green'>+22%</font>. <a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='green'>+22%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc'>GNPX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/YRIV' title='Yangtze River Port and Logistics Limited'>YRIV</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='red'>-11%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364953\" data-linked=\"Midday Gainers / Losers (06/19/2018)\" data-tweet=\"$ASTC $ASTC $GEVO - Midday Gainers / Losers (06/19/2018) https://seekingalpha.com/news/3364953-midday-gainers-losers-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364953-midday-gainers-losers-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364949\" data-ts=\"1529426240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BUROF\" target=\"_blank\">BUROF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364949-burcon-nutrascience-slides-13-post-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Burcon NutraScience slides 13% post FY results</a></h4><ul><li>Burcon NutraScience (<a href='https://seekingalpha.com/symbol/BUROF' title='Burcon NutraScience Corp.'>OTCPK:BUROF</a> <font color='red'>-13%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17194654-burcon-announces-fiscal-2018-results-reviews-operations\" target=\"_blank\">reports FY</a> revenue decrease of 37.5% Y/Y to C$0.05M.</li><li>2018 revenues decreased, as prior year&rsquo;s revenues included the recognition of C$0.04M in deferred revenues, whereas the nominal revenues reflect the company&rsquo;s development phase status&nbsp;as it transitions&nbsp;to the commercial stage.</li><li>R&amp;D expenses were C$1.9M (-13.6% Y/Y), the decrease is due to deferred development costs being fully amortized during 2017 &amp; lower salaries expenses from the termination of an employee.</li><li>Intellectual property expenses of C$1.7M (+21.4% Y/Y), the increase is due mainly to higher maintenance fees for the soy and canola portfolios due the patent prosecution activities being temporarily suspended during 2017, in addition, the company incurred higher European registration fees this year from two soy patent applications that were granted in Europe.</li><li>G&amp;A expenses C$2M (-13% Y/Y), the decrease is mostly attributed to decreases in SBC and non-cash financing expenses.</li><li>The company completed a rights offering that provided gross proceeds of C$3.5M, with net proceeds of C$3.4M.</li><li>Recently gained patent grants and allowances bring the company&rsquo;s patent portfolio to 247 issued patents in various countries, including 65 in the&nbsp;U.S., as well as more than 270 active patent applications, including 41 additional&nbsp;U.S.&nbsp;patent applications.</li><li>Cash and equivalents&nbsp;of C$3.4M (-27.7% Y/Y), the management believes it has sufficient resources to fund its expected level of operations and working capital requirements to October 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364649-burcon-nutrascience-corp-reports-fy-results\" target=\"_blank\">Burcon NutraScience Corp. reports FY results</a> (June 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364949\" data-linked=\"Burcon NutraScience slides 13% post FY results\" data-tweet=\"$BUROF - Burcon NutraScience slides 13% post FY results https://seekingalpha.com/news/3364949-burcon-nutrascience-slides-13-post-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364949-burcon-nutrascience-slides-13-post-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364950\" data-ts=\"1529425891\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364950-t-mobile-sprint-formally-file-fcc-for-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile, Sprint formally file with FCC for merger</a></h4><ul>   <li>As <a href=\"https://seekingalpha.com/news/3364352-reuters-sprint-t-mobile-file-fcc-merger-application\" target=\"_blank\">signaled</a>, T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='green'>+0.4%</font>) has <a href=\"https://ecfsapi.fcc.gov/file/10618281006240/Public%20Interest%20Statement%20and%20Appendices%20A-J%20%28Public%20Redacted%29%20.pdf\" target=\"_blank\">formally filed a Public Interest Statement</a> with the FCC seeking a $26.5B merger with Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='green'>+0.1%</font>).</li>    <li>In its filing, the company points to goals of building a world-class nationwide 5G network (\"leapfrogging Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='green'>+2.5%</font>) and AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+0.6%</font>)\"); allowing for \"cord-cutting\" on in-home broadband, and ensuring competitive gains (\"up to a 55% decrease in price per GB and as much as a 120% increase in cellular data supply\"); better rural service; and new choices for video and enterprise customers.</li>    <li>It's <a href=\"https://newtmobile.com/\" target=\"_blank\">created a website</a> where it is centralizing its case for the deal.</li>    <li>It's not an easy road ahead for the two challengers: The FCC will need to sign off on the merger, along with the Justice Dept.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364950\" data-linked=\"T-Mobile, Sprint formally file with FCC for merger\" data-tweet=\"$TMUS $TMUS $S - T-Mobile, Sprint formally file with FCC for merger https://seekingalpha.com/news/3364950-t-mobile-sprint-formally-file-fcc-for-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3364950-t-mobile-sprint-formally-file-fcc-for-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364948\" data-ts=\"1529425865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMP\" target=\"_blank\">OMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364948-oasis-midstream-signs-third-party-deals-raises-2019-ebitda-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oasis Midstream signs third party deals, raises 2019 EBITDA outlook</a></h4><ul>     <li>Oasis Midstream Partners (<a href='https://seekingalpha.com/symbol/OMP' title='Oasis Midstream Partners LP  &#40;Units&#41;'>OMP</a> <font color='green'>+3.5%</font>) is sharply higher after <a href=\"https://seekingalpha.com/pr/17194858-oasis-midstream-partners-announces-operations-guidance-update\" target=\"_blank\">signing third party agreements</a> in the Williston Basin and raising its guidance for FY 2019 EBITDA.</li>     <li>OMP says the third party projects in combination with robust growth at Oasis Petroleum (<a href='https://seekingalpha.com/symbol/OAS' title='Oasis Petroleum Inc.'>OAS</a> <font color='green'>+1.3%</font>) position it to extend its runway of 20% annualized distribution growth.</li>     <li>OMP reaffirms FY 2018 EBITDA guidance of $61-$65M while raising its FY 2019 EBITDA outlook including growth activities by 14% to $94-$97M and distribution coverage to 1.5x vs. 1.3x excluding the new agreements.</li>     <li>OMP also raises expectations for 2018 capex required to fulfill third party agreements to $285-$300M from $230-$270M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364948\" data-linked=\"Oasis Midstream signs third party deals, raises 2019 EBITDA outlook\" data-tweet=\"$OMP $OMP $OAS - Oasis Midstream signs third party deals, raises 2019 EBITDA outlook https://seekingalpha.com/news/3364948-oasis-midstream-signs-third-party-deals-raises-2019-ebitda-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3364948-oasis-midstream-signs-third-party-deals-raises-2019-ebitda-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364947\" data-ts=\"1529425667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCE\" target=\"_blank\">ONCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364947-sareptas-good-news-sparks-spark-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta&#39;s good news sparks Spark, up 6%</a></h4><ul><li>Sarepta Therapeutics' DMD gene therapy-stoked rally, shares are currently up&nbsp;<font color='green'>38%</font>&nbsp;on more than a 6x surge in volume, has spread to gene therapy developer Spark Therapeutics (<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color='green'>+6.3%</font>), albeit on below-average volume.</li><li>Spark's pipeline includes SPK-7001 for choroideremia, SPK-9001 for hemophilia B and SPK-8011 for hemophilia A.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364906-sarepta-set-pop-encouraging-data-dmd-gene-therapy\" target=\"_blank\">Sarepta set to pop on encouraging data on DMD gene therapy</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364947\" data-linked=\"Sarepta&#39;s good news sparks Spark, up 6%\" data-tweet=\"$ONCE - Sarepta&#39;s good news sparks Spark, up 6% https://seekingalpha.com/news/3364947-sareptas-good-news-sparks-spark-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3364947-sareptas-good-news-sparks-spark-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364945\" data-ts=\"1529425236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364945-verizon-ending-location-sharing-after-leaks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon ending location-sharing after leaks</a></h4><ul>   <li>After prompting from a U.S. senator, Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='green'>+2.5%</font>) says it's <a href=\"https://www.wsj.com/articles/verizon-to-cut-off-data-providers-that-gave-up-customer-locations-1529423758?mod=yahoo_hs&amp;yptr=yahoo\" target=\"_blank\">ending a location-sharing program</a> that resulted in at least one partner company sharing subscriber location without consent.</li>    <li>Verizon has shared the data with \"location aggregators\" LocationSmart and Zumigo, but says it's notified companies that \"it intends to terminate their ability to access and use our customers&rsquo; location data as soon as possible.\"</li>    <li>The company was responding to Sen. Ron Wyden, who's asked the big four U.S. wireless carriers about privacy practices.</li>    <li>&ldquo;We will not enter into new location aggregation arrangements unless and until we are comfortable that we can adequately protect our customers&rsquo; location data through technological advancements and/or other practices,\" Verizon tells Wyden.</li>    <li>Securus -- a prison telephone company unauthorized to get locations from Verizon -- began offering an expanded service letting sheriffs and corrections officers find a user's location without a court order, using data it got from a third party who had gotten it from LocationSmart.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3364945\" data-linked=\"Verizon ending location-sharing after leaks\" data-tweet=\"$VZ - Verizon ending location-sharing after leaks https://seekingalpha.com/news/3364945-verizon-ending-location-sharing-after-leaks?source=tweet\" data-url=\"https://seekingalpha.com/news/3364945-verizon-ending-location-sharing-after-leaks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364943\" data-ts=\"1529424804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364943-smartsheetminus-9_9-low-volume-no-catalyst\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet -9.9% with low volume, no catalyst</a></h4><ul><li>        Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet'>SMAR</a>) shares&nbsp;<font color='red'>drop 9.9%</font>&nbsp;with low volume and no new catalyst.</li><li>               Volume at about 574K compared to the 701.22K average.&nbsp;</li><li>               Smartsheet shares are&nbsp;<font color='green'>up 18.8%</font>&nbsp;in the past week,&nbsp;<font color='green'>65.5%</font>&nbsp;in the past month, and&nbsp;<font color='green'>65%</font>&nbsp;YTD since the IPO. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364943\" data-linked=\"Smartsheet -9.9% with low volume, no catalyst\" data-tweet=\"$SMAR - Smartsheet -9.9% with low volume, no catalyst https://seekingalpha.com/news/3364943-smartsheetminus-9_9-low-volume-no-catalyst?source=tweet\" data-url=\"https://seekingalpha.com/news/3364943-smartsheetminus-9_9-low-volume-no-catalyst\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364941\" data-ts=\"1529424431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIRI\" target=\"_blank\">SIRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364941-sirius-xm-pulls-back-from-heights-pivotal-downgrades-after-run\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sirius XM pulls back from heights as Pivotal downgrades after run</a></h4><ul>   <li>Sirius XM (NASDAQ:<a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a>) is <font color='red'>off 2.7%</font> -- and pulling back from a decade-plus high marked yesterday -- after a downgrade to Hold by Pivotal Research.</li>    <li>There's less upside after a rally driven in part by short covering, analyst Jeffrey Wlodarczak says. M&amp;A speculation also drove what has been a near-18% gain since the beginning of May, and he sees talk of a transaction with Verizon or AT&amp;T as reasonable. (h/t Bloomberg)</li>    <li>He has a price target of $7.75; shares are currently at $7.44.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364941\" data-linked=\"Sirius XM pulls back from heights as Pivotal downgrades after run\" data-tweet=\"$SIRI - Sirius XM pulls back from heights as Pivotal downgrades after run https://seekingalpha.com/news/3364941-sirius-xm-pulls-back-from-heights-pivotal-downgrades-after-run?source=tweet\" data-url=\"https://seekingalpha.com/news/3364941-sirius-xm-pulls-back-from-heights-pivotal-downgrades-after-run\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364940\" data-ts=\"1529424377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFIV\" target=\"_blank\">FFIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364940-f5-networksminus-1_7-citi-goes-to-neutral-on-fair-value\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">F5 Networks -1.7% as Citi goes to Neutral on fair value</a></h4><ul>   <li>F5 Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) is <font color='red'>down 1.7%</font> after a downgrade to Neutral at Citi, which sees fair value after growth fueled by public cloud and security deployments.</li>    <li>Analyst Jim Suva has updated the firm's price target to $190, implying 6.6% upside.</li>    <li>Shares have been on a <font color='green'>38% run</font> in 2018 and are just 2.8% below their 52-week high.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364940\" data-linked=\"F5 Networks -1.7% as Citi goes to Neutral on fair value\" data-tweet=\"$FFIV - F5 Networks -1.7% as Citi goes to Neutral on fair value https://seekingalpha.com/news/3364940-f5-networksminus-1_7-citi-goes-to-neutral-on-fair-value?source=tweet\" data-url=\"https://seekingalpha.com/news/3364940-f5-networksminus-1_7-citi-goes-to-neutral-on-fair-value\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364937\" data-ts=\"1529424052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAMI\" target=\"_blank\">FAMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364937-consumer-top-gainers-losers-of-12-00-pm-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (06/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FAMI' title='Farmmi Inc.'>FAMI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods'>ANFI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364937\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (06/19/2018)\" data-tweet=\"$FAMI $FAMI $FFHL - Consumer - Top Gainers / Losers as of 12:00 PM (06/19/2018) https://seekingalpha.com/news/3364937-consumer-top-gainers-losers-of-12-00-pm-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364937-consumer-top-gainers-losers-of-12-00-pm-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364935\" data-ts=\"1529423739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364935-sareptas-gain-ptcs-pain-down-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta&#39;s gain PTC&#39;s pain, down 17%</a></h4><ul><li>PTC Therapeutics (<a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-16.7%</font>) slumps on a 4x surge in volume in apparent response to Sarepta Therapeutics' announcement of positive preliminary data on its gene therapy candidate for Duchenne muscular dystrophy &#40;DMD&#41;.</li><li>Investors perceive a negative read-through on PTC's Translarna (ataluren).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364906-sarepta-set-pop-encouraging-data-dmd-gene-therapy\" target=\"_blank\">Sarepta set to pop on encouraging data on DMD gene therapy</a> (June 19)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3304525-ptc-4-percent-premarket-fda-crl-ataluren-application-bofa-downgrade\" target=\"_blank\">PTC down 4% premarket on FDA CRL on ataluren application and BofA downgrade</a> (Oct. 26, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364935\" data-linked=\"Sarepta&#39;s gain PTC&#39;s pain, down 17%\" data-tweet=\"$PTCT - Sarepta&#39;s gain PTC&#39;s pain, down 17% https://seekingalpha.com/news/3364935-sareptas-gain-ptcs-pain-down-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3364935-sareptas-gain-ptcs-pain-down-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364926\" data-ts=\"1529421094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SD\" target=\"_blank\">SD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364926-icahn-poised-to-win-majority-of-sandridge-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn poised to win majority of SandRidge board</a></h4><ul>     <li>SandRidge Energy (<a href='https://seekingalpha.com/symbol/SD' title='SandRidge Energy, Inc.'>SD</a> <font color='green'>+2.8%</font>) shoots higher following reports that investor Carl Icahn <a href=\"https://www.reuters.com/article/us-sandridge-agm-icahn/activist-carl-icahn-gains-control-of-board-in-proxy-fight-at-sandridge-energy-idUSKBN1JF229\" target=\"_blank\">won at least four seats</a> on the company's board, which would ensure control of the seven-seat board.</li>     <li>SD reportedly has held on to two seats, while the fate of the seventh seat is too close to call.</li>     <li>Icahn, SD's largest shareholder with a 13.5% stake, has been a persistent critic of the company&rsquo;s dealmaking and executive pay,</li></ul><div class=\"tiny-share-widget\" data-id=\"3364926\" data-linked=\"Icahn poised to win majority of SandRidge board\" data-tweet=\"$SD - Icahn poised to win majority of SandRidge board https://seekingalpha.com/news/3364926-icahn-poised-to-win-majority-of-sandridge-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3364926-icahn-poised-to-win-majority-of-sandridge-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364924\" data-ts=\"1529420769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PI\" target=\"_blank\">PI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364924-impinjminus-5_5-despite-piper-jaffray-target-boost\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impinj -5.5% despite Piper Jaffray target boost</a></h4><ul><li>        Piper Jaffray <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Impinj+Inc+%28PI%29+PT+Raised+to+%2426+at+Piper+Jaffray/14318664.html\" target=\"_blank\">maintains</a> an Overweight rating on Impinj (NASDAQ:<a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a>) and raises the price target from $19 to $26.</li><li>               Impinj shares are&nbsp;<font color='red'>down 5.5%</font>&nbsp;to $21.04. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364924\" data-linked=\"Impinj -5.5% despite Piper Jaffray target boost\" data-tweet=\"$PI - Impinj -5.5% despite Piper Jaffray target boost https://seekingalpha.com/news/3364924-impinjminus-5_5-despite-piper-jaffray-target-boost?source=tweet\" data-url=\"https://seekingalpha.com/news/3364924-impinjminus-5_5-despite-piper-jaffray-target-boost\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364923\" data-ts=\"1529420766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLDB\" target=\"_blank\">SLDB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364923-solid-biosciences-and-wave-life-sciences-go-opposite-ways-on-sareptas-positive-data-on-dmd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Solid Biosciences and Wave Life Sciences go opposite ways on Sarepta&#39;s positive data on DMD gene therapy</a></h4><ul><li>Sarepta Therapeutics is up almost&nbsp;<font color='green'>60%</font>&nbsp;on more than triple normal volume after it presented encouraging preliminary data on its gene therapy candidate for Duchenne muscular dystrophy &#40;DMD&#41; during its R&amp;D day today. Money flow has impacted two other DMD players in opposite ways.</li><li>Fellow gene therapy developer Solid Biosciences (<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+39.6%</font>) is up almost a 6x surge in volume. Yesterday, the FDA lifted its clinical hold on its Phase 1/2 study of SGT-001.</li><li>Wave Life Sciences (<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-19.2%</font>) is down on more than double normal volume on the perceived negative read-through on its DMD candidate WVE-210201, an antisense oligonucleotide.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364906-sarepta-set-pop-encouraging-data-dmd-gene-therapy\" target=\"_blank\">Sarepta set to pop on encouraging data on DMD gene therapy</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364923\" data-linked=\"Solid Biosciences and Wave Life Sciences go opposite ways on Sarepta&#39;s positive data on DMD gene therapy\" data-tweet=\"$SLDB $SLDB $WVE - Solid Biosciences and Wave Life Sciences go opposite ways on Sarepta&#39;s positive data on DMD gene therapy https://seekingalpha.com/news/3364923-solid-biosciences-and-wave-life-sciences-go-opposite-ways-on-sareptas-positive-data-on-dmd?source=tweet\" data-url=\"https://seekingalpha.com/news/3364923-solid-biosciences-and-wave-life-sciences-go-opposite-ways-on-sareptas-positive-data-on-dmd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364915\" data-ts=\"1529420436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364915-healthcare-top-5-gainers-losers-of-11-00-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/19/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='green'>+55%</font>. <a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/FMI' title='Foundation Medicine, Inc.'>FMI</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/SPRO' title='Spero Therapeutics, Inc.'>SPRO</a> <font color='green'>+25%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/GNPX' title='Genprex, Inc'>GNPX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364915\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/19/2018)\" data-tweet=\"$SRPT $SRPT $SLDB - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (06/19/2018) https://seekingalpha.com/news/3364915-healthcare-top-5-gainers-losers-of-11-00-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364915-healthcare-top-5-gainers-losers-of-11-00-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364914\" data-ts=\"1529420076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBH\" target=\"_blank\">KBH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364914-kb-home-beacon-roofing-rise-after-analyst-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KB Home, Beacon Roofing rise after analyst upgrade</a></h4><ul><li>KB Home (<a href='https://seekingalpha.com/symbol/KBH' title='KB Home'>KBH</a> <font color='green'>+0.9%</font>), and Beacon Roofing Supply (<a href='https://seekingalpha.com/symbol/BECN' title='Beacon Roofing Supply, Inc.'>BECN</a> <font color='green'>+0.3%</font>) are up in morning trading after Citi's Scott Schrier upgraded the two stocks. PulteGroup (<a href='https://seekingalpha.com/symbol/PHM' title='PulteGroup, Inc.'>PHM</a> <font color='red'>-0.2%</font>) and Masco (<a href='https://seekingalpha.com/symbol/MAS' title='Masco Corporation'>MAS</a> <font color='red'>-1.6%</font>) were also upgraded, but they're trading lower.</li><li>PHM and KBH went to neutral from sell; while BECN and MAS moved to buy from neutral, Bloomberg reports.</li><li>Overall, Citi has a constructive outlook on housing despite concern about the cycle's length, according to Schrier's note.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364914\" data-linked=\"KB Home, Beacon Roofing rise after analyst upgrade\" data-tweet=\"$KBH $KBH $BECN - KB Home, Beacon Roofing rise after analyst upgrade https://seekingalpha.com/news/3364914-kb-home-beacon-roofing-rise-after-analyst-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3364914-kb-home-beacon-roofing-rise-after-analyst-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364903\" data-ts=\"1529420071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FERGD\" target=\"_blank\">FERGD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364903-on-fergusons-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Ferguson&#39;s Q3 results</a></h4><ul><li>Ferguson (<a href='https://seekingalpha.com/symbol/FERGD' title='Ferguson plc'>OTCQX:FERGD</a> <font color='green'>+0.9%</font>) reported Q3 revenue growth of 10.2% Y/Y to $5.08B and +7.1% Y/Y organic growth.</li><li>Revenues by Geography: US $4.11B (+11.5% Y/Y), UK $629M (-10.9% Y/Y) and Canada &amp; Central Europe $342M (+8.9% Y/Y).</li><li>Trading profit was $356M up 16.3% Y/Y.</li><li>Q3 Gross margin&nbsp;<font color='green'>improved by 40 bps</font>&nbsp;to 29.3%.</li><li>Company completed sale of Stark Group on March 29, 2018 for ~$1.2B.</li><li>Company repurchased 1.9M shares for $147M during the quarter, in accordance with ongoing $650M share buyback program.</li><li>&ldquo;The US continued to grow strongly with organic revenue growth of 10.6% in the quarter. Growth was broadly based across all US regions, supported by good market conditions. We also continued to manage gross margins effectively, making further progress. We generated good growth in Canada and in the UK we continued to focus on executing the restructuring plan. The fourth quarter has started well with organic revenue growth in line with the third quarter. Given the third quarter outturn, the Group is well positioned for a successful outcome for the year\", commented John Martin, CEO.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3364782-ferguson-reports-q3-results\" target=\"_blank\">Ferguson reports Q3 results</a> (June 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364903\" data-linked=\"More on Ferguson&#39;s Q3 results\" data-tweet=\"$FERGD $FERGY - More on Ferguson&#39;s Q3 results https://seekingalpha.com/news/3364903-on-fergusons-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3364903-on-fergusons-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364911\" data-ts=\"1529419721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNK\" target=\"_blank\">GNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364911-genco-shipping-trading-completes-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genco Shipping &amp; Trading completes share offering</a></h4><ul> <li>Genco Shipping &amp; Trading (NYSE:<a href='https://seekingalpha.com/symbol/GNK' title='Genco Shipping & Trading Ltd.'>GNK</a>)&nbsp;announces that it completed its previously announced public offering of 7.015M new shares.</li><li>The company says 41.547M share&nbsp;were outstanding at the end of the offering.</li><li>Gross proceeds from the offering came in at ~$115.7M.</li><li>Genco intends to use the proceeds from the offering for future vessel acquisitions.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17195999-genco-shipping-and-trading-limited-completes-common-stock-offering\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3364911\" data-linked=\"Genco Shipping &amp; Trading completes share offering\" data-tweet=\"$GNK - Genco Shipping &amp; Trading completes share offering https://seekingalpha.com/news/3364911-genco-shipping-trading-completes-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3364911-genco-shipping-trading-completes-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364907\" data-ts=\"1529418727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYX\" target=\"_blank\">SYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364907-systemaxminus-12-sidoti-steps-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Systemax -12% as Sidoti steps to sidelines</a></h4><ul><li>        Sidoti <a href=\"https://www.streetinsider.com/Downgrades/Sidoti+Downgrades+Systemax+%28SYX%29+to+Neutral/14320512.html\" target=\"_blank\">downgrades</a> Systemax (NYSE:<a href='https://seekingalpha.com/symbol/SYX' title='Systemax Inc.'>SYX</a>) from Buy to Neutral.</li><li>               Systemax shares are&nbsp;<font color='red'>down 12%</font>&nbsp;to $34.78. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364907\" data-linked=\"Systemax -12% as Sidoti steps to sidelines\" data-tweet=\"$SYX - Systemax -12% as Sidoti steps to sidelines https://seekingalpha.com/news/3364907-systemaxminus-12-sidoti-steps-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3364907-systemaxminus-12-sidoti-steps-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364906\" data-ts=\"1529418395\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364906-sarepta-set-to-pop-on-encouraging-data-on-dmd-gene-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta set to pop on encouraging data on DMD gene therapy</a></h4><ul><li>Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) is poised for a stout up move on the heels of its <a href=\"https://endpts.com/sarepta-leads-off-duchenne-md-gene-therapy-study-with-a-home-run-on-efficacy-but-can-they-deliver-in-2-years/\" target=\"_blank\">presentation </a>of preliminary data on its gene therapy candidate for Duchenne muscular dystrophy &#40;DMD&#41; during today's R&amp;D day.</li><li>Results from three young ambulatory DMD patients treated with the gene therapy showed significant dystrophin gene expression, measured by the percentage of micro-dystrophin-positive fibers in muscle biopsy samples, and an 87% plunge in blood creatinine kinase, a biomarker for muscle damage.</li><li>No safety signals were observed.</li><li>The company believes that it could have the gene therapy available to DMD patients in as soon as two years if all goes well.</li><li>Shares have yet to resume trading. Quotes resumed at 10:23 am ET.</li><li>DMD-related tickers: (<a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+18.9%</font>)(<a href='https://seekingalpha.com/symbol/CATB' title='Catabasis Pharmaceuticals'>CATB</a> <font color='green'>+6.6%</font>)(<a href='https://seekingalpha.com/symbol/SMMT' title='Summit Therapeutics'>SMMT</a> <font color='green'>+2.4%</font>)(<a href='https://seekingalpha.com/symbol/CAPR' title='Capricor Therapeutics, Inc.'>CAPR</a> <font color='red'>-2.9%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color='red'>-5.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364906\" data-linked=\"Sarepta set to pop on encouraging data on DMD gene therapy\" data-tweet=\"$SRPT $SRPT $SLDB - Sarepta set to pop on encouraging data on DMD gene therapy https://seekingalpha.com/news/3364906-sarepta-set-to-pop-on-encouraging-data-on-dmd-gene-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/3364906-sarepta-set-to-pop-on-encouraging-data-on-dmd-gene-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364904\" data-ts=\"1529418352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364904-gevo-adds-another-40-after-skyrocketing-3_5x-yesterday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo adds another 40% after skyrocketing 3.5x yesterday</a></h4><ul>     <li>Gevo (<a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+42.4%</font>) <a href=\"https://www.marketwatch.com/story/gevo-stock-soars-more-than-300-after-epa-decision-on-gasoline-additive-2018-06-18\" target=\"_blank\">continues its spectacular surge</a> after spiking by 3.5x <a href=\"https://seekingalpha.com/news/3364666-gevo-soars-300-percent-epa-approves-higher-blend-level-isobutanol\" target=\"_blank\">yesterday</a> on news that the Environmental Protection Agency increased the volume of isobutanol that can be blended with gasoline for on-road use in cars.</li>     <li>The EPA's decision raised the amount of isobutanol to a 16% blend level from its previous 12.5% blend level.</li>     <li>Other biofuel stocks, including Green Plains (<a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='red'>-1.3%</font>) and Rex American Resources (<a href='https://seekingalpha.com/symbol/REX' title='REX American Resources Corporation'>REX</a> <font color='red'>-0.2%</font>), also rose yesterday but have pulled back today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364904\" data-linked=\"Gevo adds another 40% after skyrocketing 3.5x yesterday\" data-tweet=\"$GEVO $GEVO $GPRE - Gevo adds another 40% after skyrocketing 3.5x yesterday https://seekingalpha.com/news/3364904-gevo-adds-another-40-after-skyrocketing-3_5x-yesterday?source=tweet\" data-url=\"https://seekingalpha.com/news/3364904-gevo-adds-another-40-after-skyrocketing-3_5x-yesterday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364899\" data-ts=\"1529417791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WNDW\" target=\"_blank\">WNDW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364899-solarwindow-alliance-for-large-scale-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SolarWindow alliance for large-scale production</a></h4><ul><li>SolarWindow (<a href='https://seekingalpha.com/symbol/WNDW' title='SolarWindow Technologies, Inc.'>OTCPK:WNDW</a>) <font color='green'>+20.1%</font> in early trade after <a href=\"https://seekingalpha.com/pr/17195460-solarwindow-announces-alliance-coating-equipment-manufacturer-large-scale-production\" target=\"_blank\">announcing</a> its latest commercial alliance with nTact, a leader in coating process knowledge and equipment manufacturing, necessary for large-scale production of transparent electricity-generating windows.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364899\" data-linked=\"SolarWindow alliance for large-scale production\" data-tweet=\"$WNDW - SolarWindow alliance for large-scale production https://seekingalpha.com/news/3364899-solarwindow-alliance-for-large-scale-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3364899-solarwindow-alliance-for-large-scale-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364897\" data-ts=\"1529417557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GM\" target=\"_blank\">GM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364897-investors-bid-down-multinationals-amid-u-s-china-tension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors bid down multinationals amid U.S.-China tension</a></h4><ul> <li>The escalating trade battle between U.S. and China is leading to some jittery trading on a number of consumer-facing companies.</li><li>Xinhua News Agency reports that China is likely to once again take \"comprehensive\" measures in response to the latest U.S. tariff announcement.</li> <li>Multinationals slumping even worse than broad market averages in morning trading include General Motors (NYSE:<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a>) <font color='red'>-3.77%</font>, Expeditors International (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPD' title='Expeditors International of Washington, Inc.'>EXPD</a>) <font color='red'>-3.67%</font>, FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) <font color='red'>-2.53%</font>, UPS (NYSE:<a href='https://seekingalpha.com/symbol/UPS' title='United Parcel Service, Inc.'>UPS</a>) <font color='red'>-2.11%</font>, Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>) <font color='red'>-3.84%</font>,  Nike (NYSE:<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a>) <font color='red'>-2.11%</font> and Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>) <font color='red'>-1.72%</font>.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3364897\" data-linked=\"Investors bid down multinationals amid U.S.-China tension\" data-tweet=\"$GM $GM $EXPD - Investors bid down multinationals amid U.S.-China tension https://seekingalpha.com/news/3364897-investors-bid-down-multinationals-amid-u-s-china-tension?source=tweet\" data-url=\"https://seekingalpha.com/news/3364897-investors-bid-down-multinationals-amid-u-s-china-tension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364879\" data-ts=\"1529415045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364879-jpmorgan-strategist-upgrades-tech-consumer-staples-materials-gets-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan strategist upgrades Tech, Consumer Staples; Materials gets downgrade</a></h4><ul><li>JPMorgan&rsquo;s head of US Equity Strategy Dubravko Lakos-Bujas upgrades the tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) from Neutral to Overweight.</li><li>Lakos-Bujas cites superior organic growth, accelerating buybacks, and low macro factor correlation.</li><li>Consumer Staples (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a>) gets a boost to Neutral from Underweight due to warrant underperformance warranting a new look by fundamental investors and strategic buyers.</li><li>Materials (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLB' title='Materials Select Sector SPDR ETF'>XLB</a>) get a downgrade from Overweight to Neutral, reducing long commodity exposure. Energy stays at Overweight on low investor sentiment.</li><li>Source: Bloomberg First Word.</li><li>Tech sector is&nbsp;<font color='red'>down 1.3%</font>&nbsp;premarket to $70.86.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364879\" data-linked=\"JPMorgan strategist upgrades Tech, Consumer Staples; Materials gets downgrade\" data-tweet=\"$XLK $XLP $XLB - JPMorgan strategist upgrades Tech, Consumer Staples; Materials gets downgrade https://seekingalpha.com/news/3364879-jpmorgan-strategist-upgrades-tech-consumer-staples-materials-gets-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3364879-jpmorgan-strategist-upgrades-tech-consumer-staples-materials-gets-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364876\" data-ts=\"1529414694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364876-sarepta-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta halted pending news</a></h4><ul><li>Nasdaq has <a href=\"http://www.nasdaqtrader.com/trader.aspx?id=tradehalts\" target=\"_blank\">suspended trading</a> in Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) pending the release of news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364876\" data-linked=\"Sarepta halted pending news\" data-tweet=\"$SRPT - Sarepta halted pending news https://seekingalpha.com/news/3364876-sarepta-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3364876-sarepta-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364871\" data-ts=\"1529414214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCIP\" target=\"_blank\">OCIP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364871-oci-partners-oks-11_50-unit-tender-offer-from-oci-n-v\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OCI Partners OKs $11.50/unit tender offer from OCI N.V.</a></h4><ul>     <li>OCI Partners (NYSE:<a href='https://seekingalpha.com/symbol/OCIP' title='OCI Partners, LP'>OCIP</a>)&nbsp;<font color='green'>+1.8%</font> premarket after its conflicts committee <a href=\"https://seekingalpha.com/pr/17195781-conflicts-committee-recommends-unitholders-accept-oci-n-v-s-tender-offer-purchase-common\" target=\"_blank\">recommends accepting</a> OCI N.V.'s (<a href='https://seekingalpha.com/symbol/OCINF' title='OCI N.V.'>OTC:OCINF</a>, <a href='https://seekingalpha.com/symbol/OCINY' title='OCI N.V. ADR'>OTCQX:OCINY</a>) $11.50/unit tender offer, a 4.5% premium vs. yesterday's closing price.</li>     <li>The committee says OCI's offer to acquire all of the outstanding common units it does not already own is fair to OCIP unitholders; OCI currently owns 88.25% of OCIP units.</li><li>OCI initially offered $11/unit for OCIP <a href=\"https://seekingalpha.com/news/3361504-oci-offers-buy-remaining-oci-partners-units-11-unit\" target=\"_blank\">earlier this month</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364871\" data-linked=\"OCI Partners OKs $11.50/unit tender offer from OCI N.V.\" data-tweet=\"$OCIP $OCIP $OCINF - OCI Partners OKs $11.50/unit tender offer from OCI N.V. https://seekingalpha.com/news/3364871-oci-partners-oks-11_50-unit-tender-offer-from-oci-n-v?source=tweet\" data-url=\"https://seekingalpha.com/news/3364871-oci-partners-oks-11_50-unit-tender-offer-from-oci-n-v\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364870\" data-ts=\"1529414197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASTC\" target=\"_blank\">ASTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364870-premarket-gainers-of-9-05-06-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (06/19/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a> <font color='green'>+217%</font>&nbsp;as 1st Detect's TRACER 1000 <a href=\"https://seekingalpha.com/news/3364832-milestone-1st-detects-tracer-1000\" target=\"_blank\">reaches</a> milestone.</li>     <li><a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a> <font color='green'>+39%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364856-neurometrix-receives-3_8m-milestone-payment-collaboration-gsk-shares-ahead-40-percent\" target=\"_blank\">receiving</a> $3.8M milestone payment under its collaboration with GSK.</li>     <li><a href='https://seekingalpha.com/symbol/FMI' title='Foundation Medicine, Inc.'>FMI</a> <font color='green'>+28%</font>&nbsp;as Roche to <a href=\"https://seekingalpha.com/news/3364769-roche-buy-rest-foundation-medicine\" target=\"_blank\">acquire</a> balance of the company's shares.</li>     <li><a href='https://seekingalpha.com/symbol/GEVO' title='Gevo, Inc.'>GEVO</a> <font color='green'>+25%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364666-gevo-soars-300-percent-epa-approves-higher-blend-level-isobutanol\" target=\"_blank\">extending</a> yesterday's gain.</li>     <li><a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+16%</font>&nbsp;on canopy <a href=\"https://seekingalpha.com/news/3364830-neptune-tech-33-percent-premarket-canopy-growth-deal\" target=\"_blank\">growth deal</a>.</li>     <li><a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364810-can-fite-14-percent-premarket-encouraging-mid-stage-namodenoson-data\" target=\"_blank\">encouraging</a> mid-stage Namodenoson data.</li>     <li><a href='https://seekingalpha.com/symbol/COTV' title='Cotiviti Holdings'>COTV</a> <font color='green'>+11%</font>&nbsp;on being <a href=\"https://seekingalpha.com/pr/17195475-veritas-capital-backed-verscend-acquire-cotiviti-4_9-billion\" target=\"_blank\">acquired</a> by Verscend.</li>     <li><a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='green'>+10%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3364719-viveve-medicals-cmrf-technology-shows-positive-effect-women-sui-shares-12-percent-hours\" target=\"_blank\">positive</a> effect in women with SUI.</li>     <li><a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364870\" data-linked=\"Premarket Gainers as of 9:05 am (06/19/2018)\" data-tweet=\"$ASTC $ASTC $NURO - Premarket Gainers as of 9:05 am (06/19/2018) https://seekingalpha.com/news/3364870-premarket-gainers-of-9-05-06-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364870-premarket-gainers-of-9-05-06-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364864\" data-ts=\"1529413692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLBS\" target=\"_blank\">CLBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364864-caladrius-bio-up-25-premarket-on-accelerated-review-status-in-u-s-for-cd34-cell-therapy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caladrius Bio up 25% premarket on accelerated review status in U.S. for CD34+ cell therapy</a></h4><ul><li>Thinly traded nano cap Caladrius Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a>) is up&nbsp;<font color='green'>25%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17195326-caladrius-receives-fda-regenerative-medicine-advanced-therapy-designation-cd34-plus-cell\" target=\"_blank\">announcement </a>that the FDA has granted regenerative medicine advanced therapy &#40;RMAT&#41; status for its CD34+ cell therapy program for the treatment of refractory angina.</li><li>The designation provides for the accelerated review of the marketing application and more intensive guidance from the FDA on development.</li><li>The company in-licensed the program from Shire plc three months ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364864\" data-linked=\"Caladrius Bio up 25% premarket on accelerated review status in U.S. for CD34+ cell therapy\" data-tweet=\"$CLBS - Caladrius Bio up 25% premarket on accelerated review status in U.S. for CD34+ cell therapy https://seekingalpha.com/news/3364864-caladrius-bio-up-25-premarket-on-accelerated-review-status-in-u-s-for-cd34-cell-therapy?source=tweet\" data-url=\"https://seekingalpha.com/news/3364864-caladrius-bio-up-25-premarket-on-accelerated-review-status-in-u-s-for-cd34-cell-therapy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364863\" data-ts=\"1529413666\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAGS\" target=\"_blank\">PAGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364863-premarket-losers-of-9-05-6-19-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (6/19/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a> <font color='red'>-12%</font>.</li><li><a href='https://seekingalpha.com/symbol/TELL' title='Tellurian Inc.'>TELL</a>&nbsp;<font color='red'>-11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3364776-tellurian-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing</a> of public offering of common stock</li><li><a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a> <font color='red'>-5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364863\" data-linked=\"Premarket Losers as of 9:05 am (6/19/2018)\" data-tweet=\"$PAGS $PAGS $TELL - Premarket Losers as of 9:05 am (6/19/2018) https://seekingalpha.com/news/3364863-premarket-losers-of-9-05-6-19-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3364863-premarket-losers-of-9-05-6-19-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364862\" data-ts=\"1529413511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HK\" target=\"_blank\">HK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364862-halcon-resources-to-cut-operated-rig-count-to-three-from-four\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halcon Resources to cut operated rig count to three from four</a></h4><ul>     <li>Halcon Resources (NYSE:<a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a>) <font color='red'>-2.7%</font> premarket after saying it will <a href=\"https://globenewswire.com/news-release/2018/06/19/1526377/0/en/Halc%C3%B3n-Resources-Announces-Plans-to-Reduce-its-Operated-Rig-Activity-Level-and-Provides-an-Update-on-Other-Activities.html\" target=\"_blank\">reduce its operated rig count</a> in July from four to three, citing lower near-term realized oil prices in the Midland market.</li>     <li>HK also says it is in advanced talks to secure 25K bbl/day of firm capacity on a pipeline to the Gulf Coast, which is targeted to be in service by H2 2019; in the agreement, HK would send most of its forecast oil production to Gulf Coast markets once the pipeline is operational.</li>     <li>HK continues to expect Q2 production of 13K-14K boe/day and plans to provide updated full year guidance, including the impact of the reduced rig activity, as part of its Q2 earnings release.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3364862\" data-linked=\"Halcon Resources to cut operated rig count to three from four\" data-tweet=\"$HK $HKRS - Halcon Resources to cut operated rig count to three from four https://seekingalpha.com/news/3364862-halcon-resources-to-cut-operated-rig-count-to-three-from-four?source=tweet\" data-url=\"https://seekingalpha.com/news/3364862-halcon-resources-to-cut-operated-rig-count-to-three-from-four\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364856\" data-ts=\"1529412824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NURO\" target=\"_blank\">NURO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364856-neurometrix-receives-3_8m-milestone-payment-under-collaboration-gsk-shares-ahead-40-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NeuroMetrix receives $3.8M milestone payment under its collaboration with GSK; shares ahead 40% premarket</a></h4><ul> <li>NeuroMetrix (NASDAQ:<a href='https://seekingalpha.com/symbol/NURO' title='NeuroMetrix, Inc.'>NURO</a>) has <a href=\"https://seekingalpha.com/pr/17195153-neurometrix-receives-3_8m-milestone-payment-collaboration-gsk-consumer-healthcare\" target=\"_blank\">received</a> the first development milestone payment of $3.8M under its strategic collaboration with&nbsp;GlaxoSmithKline (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline'>GSK</a>) Consumer Healthcare.</li>   <li>The collaboration was reported in January.</li><li>NeuroMetrix shares are up&nbsp;<font color='green'>40%</font>&nbsp;premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3323176-neurometrix-inks-deal-glaxo-quell-ex-u-s-shares-ahead-68-percent-premarket\" target=\"_blank\">NeuroMetrix inks deal with Glaxo for Quell ex-U.S.; shares ahead 68% premarket</a> (Jan. 17)</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3364856\" data-linked=\"NeuroMetrix receives $3.8M milestone payment under its collaboration with GSK; shares ahead 40% premarket\" data-tweet=\"$NURO $NURO $GSK - NeuroMetrix receives $3.8M milestone payment under its collaboration with GSK; shares ahead 40% premarket https://seekingalpha.com/news/3364856-neurometrix-receives-3_8m-milestone-payment-under-collaboration-gsk-shares-ahead-40-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3364856-neurometrix-receives-3_8m-milestone-payment-under-collaboration-gsk-shares-ahead-40-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364853\" data-ts=\"1529412584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364853-reshape-nabs-u-s-patent-covering-gastric-vest-system-shares-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReShape nabs U.S. patent covering gastric vest system; shares up 6% premarket</a></h4><ul><li>Thinly traded nano cap ReShape Lifesciences (<a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17195383-reshape-lifesciences-receives-uspto-issue-notification-patent-covering-reshape-vest\" target=\"_blank\">announcement </a>that the USPTO has notified the company that it will issue a new patent covering its Gastric Vest System.</li><li>The company says the device promotes weight loss in obese patients by wrapping around the stomach and preventing expansion, thereby emulating bariatric surgery but without permanently changing anatomy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364853\" data-linked=\"ReShape nabs U.S. patent covering gastric vest system; shares up 6% premarket\" data-tweet=\"$RSLS - ReShape nabs U.S. patent covering gastric vest system; shares up 6% premarket https://seekingalpha.com/news/3364853-reshape-nabs-u-s-patent-covering-gastric-vest-system-shares-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3364853-reshape-nabs-u-s-patent-covering-gastric-vest-system-shares-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364852\" data-ts=\"1529412495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364852-snapminus-2_4-on-cowen-target-drop-to-36-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap -2.4% on Cowen target drop to 36% downside</a></h4><ul><li>           Cowen lowers its Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) price target from $10 to $9, a 36% downside to yesterday&rsquo;s close. </li><li> Analyst John Blackledge cites a survey showing slightly lower DAUs and advertising ARPU. </li><li> The survey of 2.5K US consumers over the age of 18 suggests users spent about 33 minutes/day in the app, down 7% Y/Y in Q2 through the end of May. </li><li> Blackledge forecasts Q2 end-of-period DAUs of 194M, down 2M. </li><li> Source: Bloomberg First Word. </li><li> Snap shares are&nbsp;<font color='red'>down 2.4%</font>&nbsp;premarket to $13.72.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3364852\" data-linked=\"Snap -2.4% on Cowen target drop to 36% downside\" data-tweet=\"$SNAP - Snap -2.4% on Cowen target drop to 36% downside https://seekingalpha.com/news/3364852-snapminus-2_4-on-cowen-target-drop-to-36-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3364852-snapminus-2_4-on-cowen-target-drop-to-36-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364847\" data-ts=\"1529411750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNMF\" target=\"_blank\">WYNMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364847-macau-casino-stocks-lower-on-hainan-gaming-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macau casino stocks lower on Hainan gaming development</a></h4><ul> <li>Macau stocks traded in Hong Kong ended the day lower after Bloomberg reported that some China resorts are looking to create entertainment bars in Hainan that allow betting games in which players earn redeemable points for shopping or dining.</li><li>The resorts are reportedly looking at setting up baccarat tables as well.</li> <li>Decliners in Hong Kong include Wynn Macau (<a href='https://seekingalpha.com/symbol/WYNMF' title='Wynn Macau Ltd.'>OTCPK:WYNMF</a>, <a href='https://seekingalpha.com/symbol/WYNMY' title='Wynn Macau Ltd. ADR'>OTCPK:WYNMY</a>) <font color='red'>-5.6%</font>, Galaxy Entertainment (<a href='https://seekingalpha.com/symbol/GXYEF' title='Galaxy Entertainment Group, Ltd.'>OTCPK:GXYEF</a>) <font color='red'>-3.5%</font>, Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>) <font color='red'>-3.5%</font> and MGM China (<a href='https://seekingalpha.com/symbol/MCHVF' title='MGM China Holdings, Ltd.'>OTCPK:MCHVF</a>, <a href='https://seekingalpha.com/symbol/MCHVY' title='MGM China Holdings, Ltd. ADR'>OTCPK:MCHVY</a>) <font color='red'>-3.1%</font>.</li> <li>In the U.S., Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) is <font color='red'>down 1.36%</font> in premarket trading and Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) is <font color='red'>off 2.07%</font>. Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) is <font color='red'>2.18% lower</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364847\" data-linked=\"Macau casino stocks lower on Hainan gaming development\" data-tweet=\"$WYNMF $WYNMF $WYNMY - Macau casino stocks lower on Hainan gaming development https://seekingalpha.com/news/3364847-macau-casino-stocks-lower-on-hainan-gaming-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3364847-macau-casino-stocks-lower-on-hainan-gaming-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364845\" data-ts=\"1529411727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DEA\" target=\"_blank\">DEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364845-easterly-government-shares-fall-after-upsized-share-offering-prices-19_25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Easterly Government shares fall after upsized share offering prices at $19.25 each</a></h4><ul><li>Easterly Government Properties (NYSE:<a href='https://seekingalpha.com/symbol/DEA' title='Easterly Government Properties'>DEA</a>) -<font color='red'>3.6%</font>&nbsp;after reporting that upsized public offering of 18M shares prices at $19.25 apiece.</li><li>Easterly increased the number of shares it will sell directly to 11M from 8.5M ; the number of 7M shares to be offered through forward sales agreements remains the same; greenshoe option for 2.7M added shares.</li><li>Gross proceeds to be about $346.5M; offering seen closing June 21.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17195286-easterly-government-properties-announces-pricing-common-stock-offering\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3364720-easterly-government-offer-shares-fund-430m-acquisition\" target=\"_blank\">Easterly Government to offer shares to fund $430M acquisition</a> (June 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3364845\" data-linked=\"Easterly Government shares fall after upsized share offering prices at $19.25 each\" data-tweet=\"$DEA - Easterly Government shares fall after upsized share offering prices at $19.25 each https://seekingalpha.com/news/3364845-easterly-government-shares-fall-after-upsized-share-offering-prices-19_25?source=tweet\" data-url=\"https://seekingalpha.com/news/3364845-easterly-government-shares-fall-after-upsized-share-offering-prices-19_25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364844\" data-ts=\"1529411640\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVUS\" target=\"_blank\">NVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364844-novus-on-go-mid-stage-study-of-opminus-02-in-otitis-media-shares-up-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novus on go with mid-stage study of OP-02 in otitis media; shares up 10% premarket</a></h4><ul><li>Thinly traded nano cap Novus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVUS' title='Novus Therapeutics'>NVUS</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17195211-novus-therapeutics-receives-fda-guidance-type-c-meeting-opminus-02-treatment-prevention\" target=\"_blank\">announcement </a>that the FDA is on board with the start of a Phase 2 clinical trial assessing drug/device combo OP-02 for the treatment of otitis media.</li><li>OP-02, administered via a metered dose inhaler, is comprised of a surfactant called dipalmitoylphosphatidylcholine &#40;DPPC&#41; and a spreading agent called cholesteryl palmitate &#40;CP&#41; suspended in a propellant. It is designed to restore the normal function of the Eustachian tube &#40;ET&#41;&nbsp;by reducing passive pressure on the ET enabling drainage and ventilation of the middle ear.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364844\" data-linked=\"Novus on go with mid-stage study of OP-02 in otitis media; shares up 10% premarket\" data-tweet=\"$NVUS - Novus on go with mid-stage study of OP-02 in otitis media; shares up 10% premarket https://seekingalpha.com/news/3364844-novus-on-go-mid-stage-study-of-opminus-02-in-otitis-media-shares-up-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3364844-novus-on-go-mid-stage-study-of-opminus-02-in-otitis-media-shares-up-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364839\" data-ts=\"1529410849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364839-ubs-reels-in-expectations-on-mattel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UBS reels in expectations on Mattel</a></h4><ul> <li>UBS lowers its rating on Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) to Neutral from Buy after watching shares rise 35% from their levels in March.</li> <li>The investment firm keeps a price target of $17 on Mattel.</li> <li>Shares of Mattel are <font color='red'>down 1.91%</font> in premarket trading to $17.44.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3364839\" data-linked=\"UBS reels in expectations on Mattel\" data-tweet=\"$MAT - UBS reels in expectations on Mattel https://seekingalpha.com/news/3364839-ubs-reels-in-expectations-on-mattel?source=tweet\" data-url=\"https://seekingalpha.com/news/3364839-ubs-reels-in-expectations-on-mattel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364835\" data-ts=\"1529410450\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364835-prices-plunge-for-copper-industrial-metals-trade-worries-ratchet-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Prices plunge for copper, industrial metals as trade worries ratchet up</a></h4><ul>     <li>Commodity futures including iron ore, copper, zinc and aluminum <a href=\"https://www.marketwatch.com/story/copper-industrial-metals-slide-as-us-china-trade-row-heats-up-2018-06-19\" target=\"_blank\">all tumble</a>, as the escalating trade conflict between the U.S. and China slams industrial metals directly affected by trade pacts as well as those hit by the risks of an economic slowdown.</li>     <li>In Comex futures trading, July copper recently was -1.8% at $3.0515/lb., while copper on the LME was -1.7% at $6,843/metric ton from an earlier $6,836.50, its lowest since June 1.</li><li>&ldquo;With the escalation of trade conflict between the U.S and China, copper  and other base metals will see lower prices,&rdquo; says Commerzbank analyst  Daniel Briesemann. &ldquo;<a href=\"https://af.reuters.com/article/metalsNews/idAFL4N1TL2K1\" target=\"_blank\">Market participants fear tariffs</a> on products made of  copper and other base metals.&rdquo;</li><li>In pre-market trade: <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='red'>-2.2%</font>, <a href='https://seekingalpha.com/symbol/TECK' title='Teck Resources Limited'>TECK</a> <font color='red'>-2%</font>, <a href='https://seekingalpha.com/symbol/SCCO' title='Southern Copper Corporation'>SCCO</a> <font color='red'>-1.5%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-4.2%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='red'>-3.9%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='red'>-3.6%</font>, <a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color='red'>-2.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/DBB' title='Invesco DB Base Metals ETF'>DBB</a>, <a href='https://seekingalpha.com/symbol/JJN' title='iPath DJ-UBS Nickel Total Return Sub-Index ETN'>JJN</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/BOM' title='DB Base Metals Double Short ETN'>BOM</a>, <a href='https://seekingalpha.com/symbol/BDD' title='DB Base Metals Double Long ETN'>BDD</a>, <a href='https://seekingalpha.com/symbol/JJT-OLD' title='iPath Dow Jones-UBS Tin Total Return Sub-Index ETN'>JJT-OLD</a>, <a href='https://seekingalpha.com/symbol/NINI' title='iPath Pure Beta Nickel ETN'>NINI</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a>, <a href='https://seekingalpha.com/symbol/LD' title='iPath Dow Jones-UBS Lead Total Return Sub-Index ETN'>LD</a>, <a href='https://seekingalpha.com/symbol/FOIL' title='iPath Pure Beta Aluminum ETN'>FOIL</a>, <a href='https://seekingalpha.com/symbol/JJM' title='iPath DJ-UBS Industrial Metals Total Return Sub-Index ETN'>JJM</a>, <a href='https://seekingalpha.com/symbol/BOS' title='DB Base Metals Short ETN'>BOS</a>, <a href='https://seekingalpha.com/symbol/RJZ' title='ELEMENTS Rogers International Commodity Metal ETN'>RJZ</a>, <a href='https://seekingalpha.com/symbol/BDG-OLD' title='DB Base Metals Long ETN'>BDG-OLD</a>, <a href='https://seekingalpha.com/symbol/LEDD' title='iPath Pure Beta Lead ETN'>LEDD</a>, <a href='https://seekingalpha.com/symbol/UBM' title='UBS ETRACS CMCI Industrial Metals Total Return ETN'>UBM</a>, <a href='https://seekingalpha.com/symbol/HEVY' title='iPath Pure Beta Industrial Metals ETN'>HEVY</a>, <a href='https://seekingalpha.com/symbol/JJUB' title='iPath Series B Bloomberg Aluminum Subindex Total Return ETN'>JJUB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3364835\" data-linked=\"Prices plunge for copper, industrial metals as trade worries ratchet up\" data-tweet=\"$FCX $FCX $TECK - Prices plunge for copper, industrial metals as trade worries ratchet up https://seekingalpha.com/news/3364835-prices-plunge-for-copper-industrial-metals-trade-worries-ratchet-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3364835-prices-plunge-for-copper-industrial-metals-trade-worries-ratchet-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364834\" data-ts=\"1529410425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364834-fortinetminus-3_3-on-cowen-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortinet -3.3% on Cowen downgrade</a></h4><ul><li>        Cowen <a href=\"https://www.streetinsider.com/Analyst+PT+Change/Cowen+Downgrades+Fortinet+%28FTNT%29+to+Market+Perform/14318971.html\" target=\"_blank\">downgrades</a> Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) from Outperform to Market Perform.</li><li>               Fortinet shares are&nbsp;<font color='red'>down 3.3%</font>&nbsp;premarket to $64.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3364834\" data-linked=\"Fortinet -3.3% on Cowen downgrade\" data-tweet=\"$FTNT - Fortinet -3.3% on Cowen downgrade https://seekingalpha.com/news/3364834-fortinetminus-3_3-on-cowen-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3364834-fortinetminus-3_3-on-cowen-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364833\" data-ts=\"1529410359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ITRM\" target=\"_blank\">ITRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364833-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Iterum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRM' title='Iterum Therapeutics'>ITRM</a>) initiated with Outperform rating and $24 (100% upside) price target at RBC. Initiated with Buy rating and $18 price target at Leerink. Initiated with Buy rating and $20 price target at Needham.</li><li>Bluebird bio (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) upgraded to Outperform with a $230 (30% upside) price target at Evercore ISI. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) added to US 1 list at BofA/Merrill Lynch. Shares down&nbsp;<font color='red'>1%&nbsp;</font>premarket.</li><li>Helius Medical Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HSDT' title='Helius Medical Technologies, Inc.'>HSDT</a>) downgraded to Neutral at BTIG Research.</li><li>Madrigal Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a>) downgraded to Neutral at Evercore ISI.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364833\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ITRM $ITRM $BLUE - Premarket analyst action - healthcare https://seekingalpha.com/news/3364833-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3364833-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3364830\" data-ts=\"1529409725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEPT\" target=\"_blank\">NEPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3364830-neptune-tech-up-33-premarket-on-canopy-growth-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neptune Tech up 33% premarket on Canopy Growth deal</a></h4><ul><li>Thinly traded micro cap Neptune Technologies &amp; Bioressources (NASDAQ:<a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a>) is up&nbsp;<font color='green'>33%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17195223-neptune-announces-multi-year-agreement-canopy-growth-provide-extracted-cannabis-products\" target=\"_blank\">announced </a>multiyear agreement with Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) to supplement its extraction, refinement and extract formulation capacity.</li><li>Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3364830\" data-linked=\"Neptune Tech up 33% premarket on Canopy Growth deal\" data-tweet=\"$NEPT $NEPT $CGC - Neptune Tech up 33% premarket on Canopy Growth deal https://seekingalpha.com/news/3364830-neptune-tech-up-33-premarket-on-canopy-growth-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3364830-neptune-tech-up-33-premarket-on-canopy-growth-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}